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ABSTRACT
Physical inactivity is a primary target for prevention of cardiovascular disease and type 2
diabetes. Rural Canadians are at increased risk of metabolic syndrome - a clustering of
risk factors preceding these conditions. This study investigated feasibility and
effectiveness of a stage-matched physical activity intervention using novel self
monitoring technologies in rural adults with metabolic syndrome. Adherence to self
monitoring protocols was >94%. Stage of change increased by 1 stage (p=0.001).
Physical activity increased from 5579 ± 1964 steps/day at week 1 to 7818 ± 4235
steps/day at week 8 (p=0.02). V02max increased by 17% (p<0.05). BMI decreased from
33.1 to 32.7 (p=0.016). Participants were comfortable using the technology, found it easyto-use, of low burden, and perceived it positively. This pilot study shows that this stagematched technology intervention for increased physical activity was feasible and effective
in high-risk adults in rural Ontario.

KEYW ORDS: Metabolic syndrome, stages of change, physical activity, cardiovascular
risk factors, technology, rural health
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CHAPTER 1 - INTRODUCTION
1.1 Introduction
Metabolic syndrome represents a state of metabolic dysfunction within the human
body. When regulation of glucose, lipids, and blood pressure is disrupted severe
consequences can result. Having metabolic syndrome increases the likelihood of
developing type 2 diabetes by 7-fold and doubles the risk of cardiovascular disease
(Ballantyne et al., 2008; Wilson, D'Agostino, Parise, Sullivan, & Meigs, 2005). In
Canada cardiovascular disease accounts for 30% o f annual deaths- that’s equivalent to
one Canadian every seven minutes (Statistics Canada, 2009).
Metabolic syndrome often leads to type 2 diabetes. Microvascular complications
including neuropathy, retinopathy, and nephropathy are not uncommon in this disease and
may lead to amputations, blindness, and kidney failure (Fowler, 2008). Type 2 diabetes
also increases your chances of dying from a major cardiovascular event (Almdal,
Scharling, Jensen, & Vestergaard, 2004; Huxley, Barzi, & Woodward, 2006; Sanmartin
& Gilmore, 2005). It is estimated that about 80% of diabetics die from cardiovascular
disease (Canadian Diabetes Association, 2010).
Although metabolic syndrome is widespread across Canada there exists clear
disparity between urban and rural populations. It is estimated that 14.4% of Canadians
over the age of 18 suffer from this condition (Brien & Katzmarzyk, 2006). Canadians
living in rural or remote regions are much more likely to have metabolic syndrome, and
thus, experience the consequences of this condition, than their urban counterparts (Ardem
& Katmarzyk, 2007). Rural communities have significantly limited access to health care
resources compared to their urban counterparts. For example, in 2004 only 9.4% of
physicians were located in rural communities though 21.4% o f the population resided in
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these non-urban areas (Pong & Pitblado, 2006). Since rural Canadians are particularly
vulnerable to metabolic syndrome, type 2 diabetes, and the subsequent cardiovascular
complications o f these conditions this project aims to address the needs of this
underserved high risk population. These include improved access to quality care and
primary prevention of cardiovascular disease and type 2 diabetes.
Metabolic syndrome is largely preventable because it is attributable to physical
inactivity and unhealthy dietary habits (Allbright et al., 2005; American Diabetes
Association, 2004; Ford, Kohl, Mokdad, & Ajani, 2005). Physical inactivity has been
identified as a primary modifiable risk factor for the development of cardiovascular
disease, coronary artery disease, hypertension, obesity, metabolic syndrome, and the
development of type 2 diabetes (Department of Health and Human Services, 2007;
Paffenbarger & Hyde, 1984). Some evidence suggests that up to 1 in every 10 deaths in
the United States is caused by physical inactivity (Danaei et al., 2009).
Aerobic and resistance training exercise interventions are effective methods of
preventing and managing metabolic syndrome and decreasing risk of developing
cardiovascular disease (Department of Health and Human Services, 2007; Diabetes
Prevention Program Research Group, 2002; Grundy et al., 2002; Hayes & Kriska, 2008;
Paffenbarger & Hyde, 1984). Exercise can reverse the problems of metabolic syndrome
such as glucose intolerance, hypertension, dyslipidemia, and abdominal obesity (Bo et al.,
2007; Brien, Janssen & Katzmazyk, 2007; Durstine et al., 2001; Kelley, Kelley & Tran,
2005; Khan et al., 2009; Ohkawara, Tanaka, Miyachi, Ishikawa-Takata, & Tabata, 2007).
In general, behaviour modification is complicated and difficult; exercise is no
exception. Despite attempts to encourage physically active living through health
promotion campaigns (ParticipACTION) and resources (Canada’s Physical Activity
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Guide) millions of Canadians remain sedentary (Health Canada, 2002). Information on
how to be physically active is available but it often takes more to get people moving.
Becoming physically active is as much a psycho-social process as a physical one, and
therefore researchers have drawn from the field of behaviour change psychology to help
design more effective physical activity interventions (Marcus et al., 2000).
One widely accepted theoretical approach to changing exercise behaviour is the
Transtheoretical Model o f behaviour change. Created by Prochaska and DiClemente in
the late 1970’s, this paradigm looks at behaviour change as an individualized process
taking place within the context of the individual and their environmental circumstances
(Prochaska, 1979). Interventions based on the Transtheoretical Model take stock of each
participant’s reality in terms of their stage of change (readiness to change) and then apply
the most appropriate processes of change to help modify their self-efficacy, decisional
balance, and target behaviour (Prochaska, 2005).
This approach has been found to improve adherence to short-term regular physical
activity. For example, in the PACE randomized controlled trial, Calfas and colleagues
(1995) showed that 52% o f the intervention group adopted regular physical activity (were
in the action stage) compared to only 12% of the control group after 6 weeks. Meta
analysis also shows positive short-term results of physical activity interventions based on
this model with 11/15 studies demonstrating significant improvements in physical activity
in the intervention group compared with control (Adams & White, 2003). The
Transtheoretical Model is also used by Canadian Society for Exercise Physiology fitness
professionals when making exercise recommendations (Canadian Society for Exercise
Physiology, 2004).
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In the primary health care setting, exercise prescription research has become
increasingly prevalent (Aittasolo, Miilunpalo, Stahl, & Kukkonen-Harjula, 2006; Kerse,
Elley, Robinson, & Arroll, 2005; Little et al., 2004). Most of these studies are targeted
toward sedentary adults with no specific health condition or disease making it difficult to
generalize the results to those with metabolic syndrome. There is also heterogeneity
among study designs, as some are grounded in the Theory of Planned Action, the 5A
framework for health counselling, parts of the Transtheoretical Model, or simply
modelled after other research studies. The wide variety of study designs and
interventions makes it difficult to compare studies that have been done to one another.
A handful of studies have looked at the effects of exercise on health in a metabolic
syndrome population. Lifestyle interventions targeting both diet and exercise in this
population include the Diabetes Prevention Program, the Finnish Diabetes Prevention
Study, and the Staged Nutrition and Activity Counselling (SNAC) study. The Diabetes
Prevention Program intervention focused on diet, exercise, and behaviour modification
skills as separate components, with an emphasis on self-esteem, empowerment, and social
support (Diabetes Prevention Program Research Group, 1999). Participants received
education on several behavioural skills. These include self-monitoring, goal-setting,
stimulus control, problem solving, and relapse prevention. The Finnish Diabetes
Prevention Study provided one-on-one nutritional counselling and a general exercise
prescription for aerobic and resistance training exercise for all participants (Eriksson et
al., 1999). Results of both studies showed that lifestyle intervention decreased the
incidence of type 2 diabetes in this high-risk population by -58% compared to control.
The SNAC study was a 24-week randomized controlled trial investigating the
impact of an individually tailored exercise and nutrition intervention on cardiovascular
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risk factors in a metabolic syndrome population. Based on the Transtheoretical Model,
the intervention included the STEP1M test exercise prescription and a tailored
Mediterranean-style diet. The STEPIM test exercise prescription was designed as a
practical method to assess individual aerobic fitness levels and provide stage-matched
exercise counselling and prescription within the context of the primary care setting
(Petrella & Wight, 2000; Petrella, Koval, Cunningham, & Paterson, 2003). Results of the
trial showed significant improvements in waist circumference, diastolic and systolic
blood pressure, fasting blood glucose, weight, BMI, resting heart rate, total cholesterol,
and LDL cholesterol levels in metabolic syndrome patients compared to baseline
(Aizawa, Shoemaker, Overend, & Petrella, 2009). It is unknown whether dietary changes
or changes in physical activity were the driving force behind these positive results.
1.2 Statement of the problem
The purpose of this study was to determine the feasibility and effectiveness of this
multi-dimensional approach for increasing physical activity in rural adults with metabolic
syndrome. Feasibility was assessed as adherence to the self-monitoring protocols by study
participants as well as self-reported comfort, ease-of-use, perception, and burden of the
technology from the DaTA Study Technology Experience Survey. Effectiveness was
assessed as the impact of the intervention on stage of change for physical activity as well
as physical activity, cardiorespiratory fitness, and cardiovascular risk factors.
Independent variables include the self-monitoring protocols, the parameters of the
stage-matched STEPIM test exercise prescription (frequency, intensity, type, and time for
exercise), and processes of change. Dependent variables include adherence to self
monitoring, acceptance of the technology, stage of change, VChmax, steps/day, and
cardiovascular risk factors (triglycerides, LDL cholesterol, HDL cholesterol, systolic and
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diastolic blood pressure, waist circumference, weight, BMI, fasting blood glucose,
HbAlc, and C-reactive protein).
1.3 Hypotheses
The primary hypotheses were that using the combined technology of self
monitoring devices, Blackberry1Mcell phones, and Bluetooth wireless technology to
implement a physical activity intervention targeting high-risk rural participants would be
feasible and effective. Previous studies have shown variable adherence o f rates of 34%66% for technology-based behaviour change interventions in high risk populations (Faridi
et al., 2008; Patrick et al., 2009). Therefore it was hypothesized that rural adults with
metabolic syndrome given an intervention that includes a stage-matched STEPIM test
exercise prescription and advanced technology self-monitoring tools will complete 50%
of their planned self-monitoring readings over 2 months. It was hypothesized that
participants would find the technology acceptable in terms of comfort, ease-of-use,
perception, and burden. It was hypothesized that stage of change will increase, leading to
improvements in physical activity, VC>2max, and cardiovascular risk factors.
1.4 Delimitations
The scope of this study was within the bounds of its geographical location. The
study was conducted in the small rural town o f Seaforth, Ontario, which may or may not
be representative o f all rural areas of Canada.
1.5 Limitations
Limitations o f the study include the short duration of the intervention which was
due to funding for the Blackberry

phone plans and HealthAnywhere

database

management. The study was also underpowered due to the limited number of available
BlackberrysIM. Patients were required to come to the clinic during the morning or early
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afternoon, perhaps eliminating potential participants that were unable to attend during
those times.
1.6 Assumptions
This study made several assumptions. First of all, it was assumed that Seaforth
and surrounding area is representative o f rural Canadian communities. Secondly, it was
assumed that having a spouse or family member in the study would not affect the results
of the intervention. The study did not assume that participants had any former knowledge
or training on home-monitoring devices or Blackberry™ cell phones. We did not expect
participants to have prior knowledge or experience with exercise other than walking.
1.7 Operational definitions
Metabolic Syndrome - Defined by the presence of 3 of the following criteria: waist
circumference > 102 cm in males and > 88 cm in females), high triglycerides (> 1.7
mmol/L), low HDL cholesterol (< 1.03 mmol/L in males and < 1.29 mmol/L in females),
elevated blood pressure (systolic blood pressure > 130 mmHg or diastolic > 85 mmHg),
and impaired fasting glucose (> 5.6 mmol/L) (National Heart, Lung, and Blood Institute,
2001 ) .
Type 2 diabetes - impaired fasting glucose > 7 .0 mmol/L or serum HbAlc >7%
Cardiovascular disease - a disease affecting the large or small blood vessels or the heart.
This includes macrovascular diseases such as heart attack, stroke, cardiac arrest, angina,
and coronary artery disease, as well as diseases of the microvasculature such as
neuropathy, nephropathy, and retinopathy.
Stages of change - Stage o f readiness to change physical activity behaviour.
Pre-contemplation - the individual is not considering making a change in a given
behaviour
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Contemplation - the individual is aware of the pros and cons of making a given behaviour
change but has not made a decision to change; considering making a change in the next
month
Preparation - the individual has decided that they want to make a change in thenbehaviour and is planning to take action within the next week
Action - the individual is in the process of changing their behaviour and has done so for
less than 3 months
Maintenance - the individual has made a successful change for at least 3 months
Termination - the individual has made a successful change and no longer experiences any
temptation to relapse and has 100% self-efficacy
Mediator - a variable that explains the relationship between an independent and
dependent variable
Cardiorespiratorv/aerobic fitness - one’s ability to collect oxygen and deliver it to
working tissues. Measured in terms of maximal aerobic capacity (V02max)Rural - A geographic area with low population density and wide open spaces
Self-monitoring device - A pedometer, home-blood pressure monitor, glucometer, or
Blackberry1Msmart phone
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CHAPTER TWO - LITERATURE REVIEW
2.1 Metabolic syndrome
Originally coined “Syndrome X” by Reaven in 1988, metabolic syndrome
describes a condition of metabolic dysfunction characterized by the presence of several
risk factors for developing cardiovascular disease and type 2 diabetes. Until recently there
have been multiple clinical definitions for metabolic syndrome. This lack of
standardization makes it difficult to compare studies using different criteria for metabolic
syndrome due to increased heterogeneity among patients who fall below or above the cut
points for particular risk factors.
As of October, 2009, an individual who has 3 out of 5 specific cardiovascular risk
factors is classified as having the metabolic syndrome. These 5 elements include
increased waist circumference (population-specific), elevated triglycerides (>1.7
mmol/L), low HDL cholesterol levels (< 1.03 mmol/L in males and < 1.30 mmol/L in
females), high blood pressure (systolic blood pressure > 130 mmHg and/or diastolic
blood pressure > 85 mmHg), and fasting blood glucose levels > 5.6 mmol/L. This
universal definition redefines waist circumference as specific to the population rather than
the one-size fits-all approach previously used. This is important because some
populations have a slighter build than others and those at risk may not be identified using
European values. For Canadians of European descent the cut off points for waist
circumference are >102 cm for males and >88 cm for females (Alberti et al., 2009). The
current study uses the guidelines established by the National Cholesterol Education
Program Adult Treatment Panel III prior to the publication of the current consensus
statement (National Heart, Lung, and Blood Institute, 2001). Specifically, the inclusion
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criteria used in this study include two (rather than three) of the risk factors included in the
current definition.
2.2 Complications of metabolic syndrome
Metabolic syndrome is a wide-spread and largely undiagnosed disease. In Canada,
it is estimated that at least 14.4% of adults have metabolic syndrome (Brien &
Katzmarzyk, 2006). Thousands more are likely unaware that they have metabolic
syndrome until it progresses into a disease with acute complications like type 2 diabetes
and/or cardiovascular disease. In 2001 a large screening study estimated that at least
2.2% of the Canadian population had undiagnosed type 2 diabetes and another 3.5% had
glucose intolerance. Rates may be higher, as only 25% o f patients with fasting blood
glucose >5.5 mmol/L returned for a venous blood test and of the patients who did attend
their blood test, only 50% returned for an oral glucose tolerance test (Leiter at al., 2001).
Individually the five components of metabolic syndrome predict cardiovascular
disease. For example abdominal obesity is a significant independent risk factor for future
cardiovascular events in men and women (de Koning, Merchant, Pogue, & Anand, 2007;
Lakka, Lakka, Tuomilehto, & Salonen, 2002). Hypertension, high serum triglycerides,
and low HDL cholesterol have also been shown to be significant contributors to
cardiovascular risk (Pencina, D ’Agostino, Larson, Massaro, & Vason, 2009). In
combination, these risk factors represent an even greater risk of cardiovascular disease.
2.2.1 Type 2 diabetes
Metabolic syndrome often progresses into type 2 diabetes if left untreated. In 2005
Wilson et al. followed 2549 participants in the Framingham Heart Study over 8 years.
The results show that those with metabolic syndrome at baseline were 6.9 times more
likely to develop type 2 diabetes than those who did not (RR= 6.92 for men and 6.90 for
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women) (Wilson, D'Agostino, Parise, Sullivan, & Meigs, 2005). In 2008 the ARIC study
found that metabolic syndrome risk factors predicted 81% o f all incident cases of type 2
diabetes over 9 years (Ballantyne et al., 2008). Not only does metabolic syndrome
increase the likelihood of developing type 2 diabetes, but it is also a preventable condition
in most cases.
Metabolic syndrome represents a critical point in the progression of metabolic
dysfunction. If treated with exercise and proper nutrition, it can be reversed more often
than not. Left untreated, the disease will likely progress into type 2 diabetes. Type 2
diabetics are at higher risk o f acute cardiovascular events such as myocardial infarction,
coronary artery disease, and stroke than their non-diabetic counterparts. The most recent
Canadian statistics indicate that 19.8% of Canadians with diabetes have cardiovascular
disease compared to only 4.0% of non-diabetics (Sanmartin & Gilmore, 2005). This is
consistent with studies from around the world. Results from 20-year follow-up o f the
Copenhagen City Heart Study estimate the relative risk of myocardial infarction or stroke
to be 1.7-2.7 in women and 3.5-4.6 in men with type 2 diabetes compared to age-matched
controls (Almdal, Scharling, Jensen, & Vestergaard, 2004). Type 2 diabetics are also
more likely to suffer fatal coronary heart disease than healthy controls (5.4% versus
1.6%) (Huxley, Barzi, & Woodward, 2006). The consequences of allowing metabolic
syndrome to progress into type 2 diabetes can be severe and should be prevented if
possible.
2.2.1.1 Microvascular complications o f type 2 diabetes
Diabetes increases the risk of developing chronic cardiovascular complications at
the microvascular level including retinopathy, nephropathy, and neuropathy (Fowler,
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2008). These conditions may lead to serious consequences including blindness, kidney
failure, ulcers, and even amputations.
Nephrology is the branch of medicine concerned with the kidneys (nephrology,
2010). Diabetic nephropathy is the leading cause of kidney failure in the United States
(Fowler, 2008). Kidney function appears to decline with increased duration of diabetes.
The United Kingdom Prospective Diabetes Study investigated the development and
progression of nephropathy in 5097 type 2 diabetics over 15 years. Prevalence of various
stages of nephropathy was found to increase over time from 7.3% at diagnosis to 28.0%
after 15 years of living with type 2 diabetes. Additionally 14 people eventually required
renal replacement therapy and 17 patients died due to renal disease during the course of
the study (Adler et al., 2003).
Diabetic hyperglycermia is associated with microvascular disease of the eye.
Retinopathy can take several forms including spots on the eye and the growth of extra
retinal capillaries. Unfortunately it can lead to partial or complete blindness (Fowler
2008). Metabolic syndrome is associated with increased chances of developing
retinopathy (OR=2.23, 95% Cl, 1.69-2.95) but not independently o f diabetes. In a large
cross-sectional study Keenan et al. (2009) found that incidence of retinopathy is also
associated with the number of metabolic syndrome components an individual has. With
only one risk factor present the odds ratio of developing retinopathy was 1.08 but with
five risk factors it increased to 5.31 (p < 0.001 for trend). Retinopathy is more prevalent
in type 2 diabetes than metabolic syndrome but as discussed previously, many individuals
with metabolic syndrome will develop type 2 diabetes, putting themselves at greater risk
of retinopathy.
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Diabetic neuropathy according to the American Diabetes Association is any signs
and/or symptoms of peripheral nerve damage not attributable to a particular cause
(American Diabetes Association, 2007). Neuropathy can cause poor circulation, ulcers,
and impair wound healing. It is estimated that about 80% o f all foot amputations that
happen after injury or ulcer are caused by nerve damage due to hyperglycaemia (Fowler,
2008). For those with type 2 diabetes this is a brutal consequence of a largely preventable
condition.
Components o f the metabolic syndrome that are shared by type 2 diabetes are
associated with an increased risk of neuropathy. In particular, high levels of HbAlc and
fasting blood glucose are indicative of future neuropathy and its complications. Several
cross-sectional studies have shown a significant correlation between hyperglycaemia and
neuropathy in type 2 diabetics that meet the criteria for metabolic syndrome (Hsu, Yen,
Liou, Wang, & Chen, 2009; McClean, Andrews, & McElnay, 2005; MetaScreen Writing
Committee, 2006). No high quality epidemicological studies were found investigating the
prevalence and risk of neuropathy in metabolic syndrome alone.
2.2.3.2 Macrovascular Disease
Cardiovascular disease is the number one cause of death in the United States
(Rosamond et al., 2008). Metabolic syndrome contributes to this death toll because it
represents a state of metabolic dysfunction that increases cardiovascular risk. Meta
analysis of 21 prospective studies between 1966 and 2005 shows evidence that metabolic
syndrome increases the relative risk of developing cardiovascular disease compared with
individuals who do not have metabolic syndrome (RR=1.52; 95% Cl. 1.26-1.87) (Galassi,
Reynolds, & He, 2006).
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Myocardial infarction and angina pectoris represent the most common diseases of
the coronary arteries. Commonly known as a heart attack, myocardial infarction happens
when arterial plaque causes a blockage in one of the coronary arteries. The majority of
coronary blockages (55-60%) occur when a vulnerable plaque breaks off upstream and
subsequently gets lodged in a section of the coronary vessel that has severe plaque build
up and a narrow lumen (Virmani, Burke, Farb, & Kolodgie, 2006). The myocardium
(heart muscle) requires oxygen to contract so when one of the arteries that supply the
heart with oxygen becomes blocked, the heart cannot keep working at full capacity or for
long. Even with immediate medical attention irreversible damage to part or all of the
myocardium can result. Angina is a condition characterized by the symptoms of
myocardial infarction but is caused by reduced delivery of oxygen to the heart due to
narrowing o f the coronary blood vessels rather than a complete blockage. Symptoms are
usually relieved by using nitro-glycerine, a powerful vasodilator which widens the blood
vessels and permits more oxygen to reach the heart.
Overall, coronary heart disease represents >50% of all cardiovascular events in
men and women less than 75 years of age (Rosamond et al., 2008). Metabolic syndrome
has been associated with an increased risk of myocardial infarction and vice versa. In
2009 a clinical study in Nepal found that 26.19% of patients diagnosed with acute
myocardial infarction also had metabolic syndrome. The researchers also found that the
presence of metabolic syndrome was significantly greater among younger patients (ages
40-49) than in older patients, with a prevalence of 75% (Pandey et al., 2009).
In 2008 the ARIC study compared 12,089 individuals with and without metabolic
syndrome at baseline and 9 year follow up. Comparing those with metabolic syndrome to
those without, the hazard ratio of developing incident coronary heart disease was found to
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be 1.46 (95% Cl, 1.23-1.74) for men and 2.05 (95% Cl, 1.59-2.64) for women
(Ballantyne et al., 2008). As these results show, metabolic syndrome is often a precursor
to serious cardiovascular events.
It is estimated that every 40 seconds an adult in the United States has a stroke
(Rosamond et al., 2008). Metabolic syndrome is associated with an increased risk of
experiencing an acute stroke. Recent meta-analysis of 13 prospective cohort studies from
the United States and China shows when comparing those with metabolic syndrome to
those who do not, the age-adjusted relative risk o f having a stroke is 1.61 (95% Cl, 1.48
1.75) (Li et al., 2008). Independently 9/13 of these studies showed a significant increased
relative risk of stroke in metabolic syndrome individuals (Li et al., 2008).
2.3 Prevalence in rural Canada
Metabolic syndrome is prevalent in rural areas of Canada. In 2006 Brien and
colleagues estimated the overall prevalence of metabolic syndrome in Canada to be about
14.4% (17.5% in men and 11.2% in women) based on a sample of 12,881 adults across 10
provinces who completed the Canadian Heart Health Surveys between 1986 and 1992
(Brien & Katzmarzyk, 2006). Ardem and Katmarzyk found that there were significant
differences between provinces, with the highest rates of metabolic syndrome occurring in
the Atlantic provinces (16.6% in P.E.I., 18.0% in NS, 20.7% in NB, and 22.8% in
NFLD). Prevalence of metabolic syndrome was lowest in British Columbia (12.8%)
(Ardern & Katmarzyk, 2007). This suggests a regional trend in which individuals living
in the predominately rural areas of Canada are more likely to have metabolic syndrome
than those who live in urban areas. Evidence from another study supports this evidence,
showing that rural Canadians are much more likely to have metabolic syndrome and/or
undiagnosed type 2 diabetes than city-dwellers (Leiter et al., 2001).
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Rural Canadians are also at increased risk of the individual risk factors that make
up the metabolic syndrome. A report published by the Canadian Institute for Health
Information (2006) shows that living in rural Canada is independently associated with
elevated risk of being overweight or obese, hypertensive, and/or diabetic. Dyslipidemia
and hypertension are prevalent risk factors in the Ontario adult population. In a large
retrospective cohort study of 46,322 patients South-western Ontario, Canada, the
prevalence of hypertension and dyslipidemia was 17.6% and 12.3%, respectively (Petrella
& Merikle, 2008).
In 2006, Shields & Tjepkema estimated that 23% of Canadian adults were obese
and another 36% were overweight. Regional trends in obesity parallel those of metabolic
syndrome from Ardem & Katzmarzyk (2007), with the highest proportion of obese adults
in Newfoundland (34%) and the smallest in British Columbia (18%). In Ontario it is
estimated that 21% of urbanites are obese compared to 28% of non-city dwellers. Also of
note is that the obesity rate of the Greater Toronto Area is only 16% which is much lower
than the provincial average (Shields & Tjepkema, 2006).
2.4 Benefits of exercise on metabolic syndrome
Physical inactivity has been identified as a primary modifiable risk factor for the
development of metabolic syndrome, type 2 diabetes, and the cardiovascular
complications that accompany these diseases (Department of Health and Human Services,
2007; Diabetes Prevention Program Research Group, 2002; Grundy et al., 2002; Hayes &
Kriska, 2008; Paffenbarger & Hyde, 1984). Evidence shows that adults who are
sedentary are at increased risk of developing metabolic syndrome than adults who engage
in 150 min/week or more of moderate to vigorous physical activity (OR=l .90, 95% Cl,
1.22-2.97) (Ford, Kohl, Mokdad, & Ajani, 2005).
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Physical activity is known to produce many general health benefits (for a review
see Warburton, Nicol, & Bredin, 2006) as well as physiological improvements in the risk
factors that contribute to metabolic syndrome (Bo et al., 2007; Brien, Janssen &
Katzmarzyk, 2007). Exercise can improve blood lipid profiles (Durstine et al., 2001;
Kelley, Kelley & Tran, 2005), lower blood pressure (Khan et al., 2009), and decrease
abdominal fat (Ohkawara, Tanaka, Miyachi, Ishikawa-Takata, & Tabata, 2007). Strong
evidence shows that exercise is associated with a decrease in overall risk of
cardiovascular morbidity and mortality (Paffenbarger & Hyde, 1984; Sandrock, Schulze,
Schmitz, Dickhuth, & Schmidt-Trucksaess, 2008).
Lifestyle interventions specifically targeting high-risk individuals with metabolic
syndrome have shown promising results. The Diabetes Prevention Program study, a large
randomized controlled trial in the United States, found that lifestyle intervention
including physical activity counselling reduced the incidence of type 2 diabetes by 58%
(95% Cl, 48-66%) compared to control (Diabetes Prevention Program Research Group,
2002). In 2005 Orchard and colleagues reported resolution rates of metabolic syndrome
for participants in the Diabetes Prevention Program. O f participants who had metabolic
syndrome at baseline, 38% o f the lifestyle group and 18% of the placebo group had
reversed their condition at 3 years. These results support the use of lifestyle intervention
to treat metabolic syndrome.
A second randomized controlled trial, the Finnish Diabetes Prevention Study, also
showed that lifestyle changes can improve cardiovascular risk factors and reverse
metabolic syndrome. Along with healthy eating advice, participants in the intervention
group received individually tailored exercise instruction. After three years the healthy
lifestyle group improved their metabolic syndrome profile and reduced their incidence of
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type 2 diabetes 58% more than the control group (Tuomilheto et al., 2001). Lifestyle
interventions focusing on diet and exercise behaviours have shown promise for
preventing type 2 diabetes and reversing metabolic syndrome.
It has been recognized that changing human behaviour is a complex process and
that even the best exercise intervention won’t work unless you actually do it. Thus, using
a behaviour change model to inform an exercise or lifestyle intervention is essential for
success.
2.5 Transtheoretical model-based exercise interventions & the metabolic syndrome
2.5.1 The transtheoretical model & exercise behaviour change
The Transtheoretical Model proposes three major constructs of behaviour change:
stages of change (Table 1), processes of change (Table 2), and the mediators between
them (Prochaska, Redding, Harlow, Rossi, & Velicer, 1994). Stages of change represent
different psychological states of preparedness to change a particular habit; they act as the
dependent variable in the model. Processes of change are the thoughts and actions that
help or lead individuals to make changes in their behaviour; these are the independent
variables. Different processes of change tend to be used at different stages of change
(Prochaska & DiClemente, 1983; Prochaska, 2005). Processes of change also influence
decisional balance, self-efficacy/temptation, and the target behaviour. Mediators are
variables that explain the relationship between an independent variable (like processes of
change) and a dependent variable (stage of change). In the Transtheoretical Model
mediating variables include decisional balance, self-efficacy/temptations, and target
behaviours. Decisional balance involves the weighing the pros and cons of continuing a
behaviour and/or adopting a new behaviour. Generally as an individual goes through the
stages of change pros of changing their behaviour increase and cons decrease (Prochaska,
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Redding, Harlow, Rossi, & Velicer, 1994). Self-efficacy represents an individual’s
situation-specific confidence that they will be able to make a particular change in
behaviour and overcome temptation, the salience of cues to engage in the problem
behaviour. As a person starts to successfully change their behaviour, their confidence in
being able to continue and overcome temptations improves (Prochaska & DiClemente,
1982). Finally, target behaviours are measures of how successfully an individual is
adopting (or quitting) a particular behaviour. Each of these mediators predicts stage
progression which is the outcome of interest in the Transtheoretical Model (Prochaska,
Redding, Harlow, Rossi, & Velicer, 1994). Figure 1 shows the relationship between the
processes of change, self-efficacy/temptation, decisional balance, and the stages of
change.
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Table 1
Stages o f Change fo r Physical Activity in the Transtheoretical Model

Stage of Change

Description

Pre-contemplation

The individual is not contemplating making a change in
physical activity behaviour

Contemplation

The individual is aware of the pros and cons of changing
physical activity behaviour but is “on the fence” about
making a change

Preparation

Pros of changing physical activity behaviour outweigh
cons. The individual has decided to make a change and
is planning to take action within the next month

Action

The individual is now increasing their physically activity
or has been engaging in regular physical activity for less
than 3 months

Maintenance

The individual has been regularly physically active for at
least 3 months

♦Termination

The individual has 0 temptation and 100% self-efficacy
regarding their physical activity behaviour (rare)

Note: Termination Stage is not included in the early versions of the model, is rare in real
life, and not used in most interventions.
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Table 2
Processes o f Change fo r Physical Activity from the Transtheoretical Model

Process of Change

Description

Consciousness-raising

Involves increased awareness of the consequences of
being physically inactive and the benefits of becoming
physically active.

Dramatic Relief

Involves emotional arousal about one’s current
behaviour and relief that can come from changing.

Environmental Re-evaluation

Involves assessing one’s current social environment and
how becoming physically active would impact that
environment.

Self Re-evaluation

Involves re-assessing one’s image and empowering
oneself to make changes.

Self Liberation

The belief that one can change and the commitment to
act on that belief.

Social Liberation

Changes in the social environment that make it easier to
behave in a particular way. (i.e. laws prohibiting
smoking indoors may help you quit smoking)

Reinforcement Management

Involves the systematic use of reinforcements for taking
steps in the right direction.

Helping Relationships

Involves positive and supportive relationships that
encourage one’s physical activity journey.

Counter-conditioning

Involves substituting healthy behaviours for unhealthy
ones.

Stimulus Control

Involves modifying one’s environment to increase cues
for positive behaviours and decrease cues for negative
behaviours.
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Figure 1. The Transtheoretical Model of Behaviour Change

2.5.2 Effectiveness of exercise interventions using a transtheoretical approach
Although originally used to describe non-exercise behaviours, the Transtheoretical
Model of behaviour change is now commonly applied to exercise adoption, adherence,
and maintenance. It has become a useful model to develop and implement exercise
interventions and programs tailored to individuals’ needs. This is done by first assessing
an individual’s stage of change for physical activity. Then stage-matched exercise
recommendations that use the most appropriate processes of change for that stage are
given. Processes of change are thought to facilitate changes in self-efficacy, decisional
balance, and target behaviour which in turn facilitate progressions in stage of change
{Figure 1).
The literature suggests that short-term stage-matched physical activity
interventions are effective (Adams & White, 2003). One of the most successful exercise
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interventions based on the Transtheoretical Model is the Physician-based Assessment and
Counselling for Exercise (PACE) study. Calfas and colleagues applied the
Transtheoretical Model to a sample of sedentary patients (mean age 39.4) with Hepatitis
B in a primary care setting. Patients’ stage of change was assessed using an 11-item
questionnaire designed for the PACE study. Those in the pre-contemplation stage were
asked to consider the personal benefits of being physically active and encouraged to think
about starting a program. Patients in the contemplation group worked with their
physician to establish a physical activity goal, come up with ways to overcome barriers,
and identify helping relationships. Finally, patients who were currently active were
provided with verbal reinforcement and discussed strategies to prevent relapse. After 6
weeks 52% of the contemplators in the intervention group moved from the contemplation
stage to the action stage compared to only 12% of the control group. Self-reported
physical activity increased by 10 min/week in the control group and 40 min/week in the
intervention group. Accelerometer data confirmed a 33% increase in the intervention
group and a slight decrease in the control group. The PACE study showed that physical
activity interventions tailored to individuals’ stage of change can be effective in the short
term in a young sedentary population (Calfas et al., 1996).
Long-term benefits of a physical activity intervention based on the
Transtheoretical Model have not been confirmed. In 2005 the PACE study was repeated
in the Netherlands over a one-year period. This randomized controlled trial enrolled and
randomized 358 patients to either usual care or the PACE intervention. Results showed no
significant differences between groups in progression of stage of change or increases in
physical activity levels. However, both the usual care and the PACE participants did
significantly increase their overall physical activity, suggesting that physical activity
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counselling is effective whether it is included as part of usual care or as part of the PACE
protocol (van Sluijs et al., 2005). It is also important to remember that the
Transtheoretical Model is not a linear paradigm - according to Prochaska & DiClemente
(1983), the stages of change are dynamic and often involve many failed attempts before
successful change is adopted. Long-term interventions are more susceptible to stage
regression (relapse) than short-term programs, which may explain why short-term
interventions appear more successful.
The STEP™ test exercise prescription is grounded in the Transtheoretical Model.
Stages of change are assessed initially, and exercise counselling and prescription based on
ACSM guidelines are tailored to individuals’ stage of change and fitness level. Stagematched written activities are also provided to individuals. These activities address
processes of change appropriate to each stage and aim to facilitate improvements in
decisional balance, self-efficacy, skills for coping with temptation, and physical activity
levels. The major advantage of the STEP™ test exercise prescription over previous
protocols grounded in the Transtheoretical Model is that it also provides a valid and
reliable estimate of maximal aerobic fitness. This information is essential to provide a
tailored exercise prescription that is appropriate for the individual’s current physical
fitness. The STEP™ test integrates the psycho-social aspects of behaviour modification
with the physiological aspects of exercise prescription (Petrella, Koval, Cunningham, &
Patterson, 2001; Petrella, Koval, Cunningham, & Patterson, 2003; Petrella & Wight,
2000 ).
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2.5.3 Exercise interventions using a transtheoretical model approach for metabolic
syndrome
Diabetes prevention research focusing on lifestyle changes including physical
activity has infrequently used the Transtheoretical Model. Two of the most famous
diabetes prevention studies, the Diabetes Prevention Program and the Finnish Diabetes
Prevention Study, provided education and training on behaviour modification skills but
lacked vigorous theoretical backing for these strategies. The Diabetes Prevention
Program enlisted the aid of specialists with prior training in nutrition, exercise, or
behaviour modification to deliver the content of their program. Topics covered for
behaviour modification were self-monitoring, goal-setting, stimulus control, problem
solving, and relapse prevention. Despite the fact that this combines ideas from several
paradigms, the authors only make reference to motivational interviewing (The Diabetes
Prevention Program Research Group, 1999). The Finnish Diabetes Prevention Study on
the other hand doesn’t mention any specific theoretical approach to their lifestyle
intervention (Eriksson et al., 1999).
The Staged Nutrition and Activity Counselling trial (SNAC) is a precursor to the
current study. This trial examined the effectiveness of a STEP1Mtest exercise
prescription and a staged Mediterranean diet on cardiovascular function and structure in
patients with metabolic syndrome and/or hypertension. This study used the Stage of
Change for Physical Activity Questionnaire, as well as a staging algorithm for the
Mediterranean diet with subsequent stage-appropriate counselling and prescription for
diet and exercise from their physician. The SNAC intervention had positive effects on
metabolic syndrome components: fasting blood glucose, waist circumference, LDL
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cholesterol, and blood pressure decreased significantly (p < 0.05) (Aizawa, Shoemaker,
Overend, & Petrella, 2009).
A similar trial has recently been initiated in Kingston, Ontario. In 2009 Ross and
colleagues described the methods and design of a large randomized trial comparing a
stage-matched Mediterranean diet and physical activity intervention to usual care in a
high-risk obese population. This research differs from the SNAC study because it does
not measure physical fitness or use the STEP™ test exercise prescription. Results are not
yet available.
To our knowledge there has not been a study investigating the impact of a
STEP™ test exercise prescription intervention without dietary intervention on a rural
metabolic syndrome population.
2.5,4 The STEP™ Test Exercise Prescription
The STEP™ test exercise prescription began as a self-paced stepping protocol.
The self-paced stepping test comes out o f the work of several faculty members at the
University of Western Ontario. In the late 1990’s a randomized trial was conducted to
validate a self-paced stepping test at normal and fast stepping speed as a predictive
submaximal test for V02max in community-dwelling older adults. The results of the
stepping test were compared to direct measurement of V 0 2 max from a commonly used
maximal treadmill test. The results showed that performing the test at normal and fast
speeds yielded the same results. Correlation of predicted V02max was high (0.96) between
the self-paced stepping test and the maximal treadmill test with direct measurement of
V02max (Petrella, Koval, Cunningham, & Paterson, 1998). The self-paced stepping test
was found to be reliable and valid for predicting maximal aerobic capacity in older adults
(Petrella, Koval, Cunningham, & Paterson, 2001).
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It is also a practical and feasible test to perform in clinical practice (Petrella &
Wight, 2000). In 2003 a randomized controlled trial was preformed to assess the
potential benefits o f using the self-paced stepping test combined with stage-matched
Tn #

exercise prescription (referred to as the STEP

______ 'T’ l /

test exercise prescription, or STEP

).

After 1 year, VC^max increased by 14% in the STEPIM group compared with 3% in the
control group (pO .001). Exercise self-efficacy was significantly higher in the STEP1M
group compared with control (32% versus 22% increase, respectively). The STEP™
group also dropped their systolic blood pressure by 7.3% and BMI by 7.4%, whereas the
control group experienced no significant changes in these outcomes (Petrella, Koval,
Cunningham, & Paterson, 2003). These results show that the STEP™ test is effective in
facilitating increases in cardiorespiratory fitness through increased physical activity.
2.6 Patient self-monitoring and technology
Self-monitoring technology has been available to the public for several years.
Advances in technology have improved access to self-monitoring devices including home
blood pressure monitors, glucometers, pedometers, and heart rate monitors. Self
monitoring of blood glucose is an effective tool for increasing glucose control (Poolsup,
Sukomboon, & Rattanasookchit, 2009). Likewise, self-monitoring of home-blood
pressure has been recommended to help enhance blood pressure control in hypertensive
patients (McManus et al., 2008). Physical activity interventions often rely on self
monitoring of physical activity using pedometers. Pedometers are widely available and
have high convergent validity with other measures of physical activity including
accelerometers (mean r = 0.86) and self-reported walking or running distances (TudorLocke, Williams, Reis, & Pluto, 2002). A recent meta-analysis by Bravata et al. (2007)
shows that pedometer-based physical activity interventions helped participants increase
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daily physical activity by at least 2100 steps/day. The evidence shows that using self
monitoring devices can improve health outcomes and physical activity.
2.6.1 Cell phone technology for health interventions
Access to advanced communications technology has improved drastically over the
last 20 years. The majority of Canadians have home access to the internet and a cell
phone on hand at all times. Cell phones are lightweight, portable, and have a variety of
functions such as text messaging, email, internet, and Bluetooth capabilities that make
them a versatile technological tool, ideal for interventions fusing technology and self
monitoring for health.
Health interventions using cell phones have used built-in reminders, automated or
real-time text-messages, and automatic data transfer using Bluetooth wireless technology.
Recent studies have employed cell phones for everything from improving sunscreen use
(Armstrong et al., 2009) to quitting smoking (Obermayer, Riley, Asif, & Jersino, 2009;
Whittaker et al., 2009) and losing weight (Patrick et al., 2009) with varying degrees of
success.
Cell phone technology has been used to enhance blood pressure control in
hypertensive patients. Park, Kim, and Kim (2009) implemented an 8-week quasi
experimental trial of blood pressure self-monitoring study using two-way cell phone SMS
text messaging and an interactive website in 49 obese hypertensive adults. Participants
were instructed to monitor their blood pressure at their convenience and were given
automatic feedback via SMS text messaging or a website. Weekly tailored
recommendations were provided electronically by a study nurse. Results showed
significant decreases in systolic blood pressure (-9.1 mmHg) and diastolic blood pressure
(-7.2 mmHg) in the treatment group, with no changes in the control group.
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Cell phones have showed promise for enhancing glucose control in
hyperglycaemic patients. In 2005 Farmer and colleagues described a real-time telehealth
system centered on data transmission to and from a mobile phone. This system was
targeted to diabetic populations whose primary self-monitoring outcome is blood glucose.
Patients were monitored by a data management system that sends alerts when patients
were above or below pre-set glucose levels or missed readings. Cho, Lee, Lim, Kwon,
and Yoon (2009) demonstrated the effectiveness of the Diabetes Phone, a specialized cell
phone capable of functioning as a glucometer and a cell phone, in lowering H bA lc levels
over 3 months in middle-aged type 2 diabetics. The NICHE study in Connecticut, United
States, studied the feasibility of using cell phones paired with self-monitoring devices to
improve glucose control and physical activity in type 2 diabetics. In this randomized pilot
study, 15 participants monitored their blood glucose using glucometers and their daily
physical activity via pedometers while 15 participants received usual care. Data was
transferred wirelessly to their cell phones and then to the study database in real time.
Results o f the NICHE trial showed that the use of these technologies was feasible but
adherence varied considerably across participants from 100% (n=2) to 0% (n=5) (Faridi
et al., 2008). This suggests that interventions combining self-monitoring and cell phone
technology can be effective but may depend on individual factors like motivation and
readiness to change behaviour.
Cell phone and internet technologies have also been employed to increase
physical activity in sedentary adults. Hurling et al. (2007) investigated the impact of a cell
phone and web-based behaviour change system for increasing physical activity in middleaged sedentary adults. Participants in the intervention group wore accelerometers and
received automated dialogue therapy via SMS text messaging to help identify barriers and
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offer solutions. They reported physical activity on the research program website weekly
and could opt to send reminders for physical activity via text or email for the upcoming
week. After 9 weeks the intervention group was active for 138 min/week more than the
control group according to accelerometer data.
2.6.2 Applications to Metabolic Syndrome
Treatment recommendations for metabolic syndrome patients include making
lifestyle changes like exercising more. Evidence shows that making behavioural changes
is extremely challenging. In fact, Prochaska & DiClemente found that even those who
successfully quit smoking failed multiple times before making a successful change
Prochaska and DiClemente, 1983). Having social support, being motivated, and being
ready to change contribute tremendously to successfully adopting regular physical
activity (Prochaska & DiClemente, 1982).
BlackberryIM smart phones combined with remote health monitoring tools have
the potential to facilitate the processes of change. One of the ways it might do this is by
providing patients with physiological feedback regarding the impacts of their behaviours
on their health. For example, having a glass of wine late in the evening will show up as
elevated blood glucose levels before bed. Theoretically, this is a form of consciousness
raising, one o f the processes of change from the Transtheoretical model. Automated
reminders also serve to increase awareness about decisions on a day-to-day basis and may
help individuals make different choices or think differently about the consequences of
their choices. Having constant support and reminders may also help keep people
motivated toward reaching their goals.
Cell phone-based interventions targeting physical activity in a metabolic
syndrome population have not been done. Past studies show that interventions combining
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cell-phone and self-monitoring technologies are promising for blood glucose and blood
pressure control, as well as increasing physical activity and promoting weight loss. The
current study will integrate all of these components with a STEP1M test exercise
prescription intervention targeting a rural metabolic syndrome population.
2.6.3 Potential benefits for remote & rural populations
Incidence of metabolic syndrome is prevalent in rural areas of Canada which tend
to have a high numbers of patients without family doctors. Rural and remote communities
have significantly limited access to health care resources compared to their urban
counterparts. In 2004 only 9.4% of physicians were located in rural communities though
21.4% of the population resides in these non-urban areas (Pong & Pitblado, 2006). It has
also been shown that living in a rural or non-metropolitan area can increase wait times
and lower your chances of receiving specialized care from a cardiologist after an acute
myocardial infarction compared to those living in metropolitan centres (Hassan et al.,
2009).
Technology has been cited as a potential solution to improve access to health care
in rural Canada. In 2002 the Government of Canada issued the Romanow report which
recommended that the federal government establish a Rural and Remote Access Fund to
support new initiatives for health care delivery to people in remote and rural
communities. This report highlighted the potential for technology to help bridge the gap
between rural populations and health care access (Romanow, 2002, pp. 159-169).
Using cell phone and home-based self-monitoring technologies is a cost-effective
and novel way to improve access to care and address issues of health care provider
shortages and an aging population (Celler, Lovell, & Chan, 1999). Qualitative analysis
from a study in Northern Ontario shows that using video technology to provide health
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care to patients in rural Canada can increase patients’ sense of security, improve care, and
significantly reduce the emotional and financial burdens of travelling to city centres for
health care (Sevean, Dampier, Spadoni, Strickland, & Pilatske, 2009). Another study
from Northern Ontario implemented a home telehealth unit with peripheral self
monitoring devices for multiple chronic conditions in frail older adults. The home care
unit collected data from the peripheral monitoring devices and transmitted it to a secure
server via telephone wires or the internet. Qualitative data at 1 year suggested that the
majority of the patients were highly satisfied with the system. They found it easy-to-use
and useful, and it provided patients with a sense of security (Liddy et al., 2009).
The literature shows good acceptance of telehealth systems in rural and remote
communities in Ontario. To our knowledge there have not been any studies using
Blackberry1Msmart phones combined with Bluetooth-enabled self-monitoring devices in
a rural adult population with metabolic syndrome.
2.7 Summary
Metabolic syndrome increases the risk of a host of cardiovascular events and
complications. Rural patients are at increased risk of metabolic syndrome and reduced
access to health resources. Evidence shows that regular exercise improves cardiovascular
risk factors. Home self-monitoring and cell-phone technology have the potential to
enhance patient adherence and support during an exercise intervention. Improved
compliance to the intervention and physiological feedback may improve patient
outcomes. The Transtheoretical Model provides a theoretical basis for the STEP™ test
exercise prescription which has been effective in increasing physical activity and aerobic
fitness in a metabolic syndrome population. The Diabetes and Technology for Increased
Activity (DaTA) study is a multi-faceted exercise intervention targeting metabolic
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syndrome patients in rural Canada. This 2-month pilot project is the first study
integrating the STEP™ test exercise prescription with self-monitoring devices,
Blackberry™ smart phones, and Bluetooth technology. This is also the first study to
apply such an approach to a physical activity intervention in a rural metabolic syndrome
population.
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CHAPTER THREE - METHODOLOGY
3.1 Study design
We conducted a pre-post pilot study to evaluate the feasibility and effectiveness of
using Blackberry1Mand Bluetooth self-monitoring technologies during a stage-matched
STEP1M test exercise prescription in rural patients with metabolic syndrome. Feasibility
was assessed as adherence to the self-monitoring protocols and participant perception of
the technology in terms of comfort, ease of use, perception, and burden. Effectiveness of
the intervention was assessed in terms o f stage of change for physical activity and
improvements in physical activity, fitness, and cardiovascular risk factors.
Participants came to the Gateway Rural Health Research Institute for clinic visits
at baseline, 1 month, and 2 months (study end). At each clinic visit blood samples were
collected for measurement of blood lipids, HbAlc, and C-reactive protein. A complete
physical examination that included measurements of weight, height, and waist
circumference was completed. Participants completed the Stages of Change for Physical
Activity Questionnaire (Marcus, Selby, Niaura, & Rossi, 1992) at each visit and the
DaTA Study Technology Experience Survey at visit 2 and visit 3. The STEP1Mtest was
completed at each visit followed by goal setting and a stage-matched exercise
prescription. Participants received a stage-matched activity booklet addressing self
efficacy, decisional balance, and stage-appropriate processes of change.
At baseline participants were given several self-monitoring devices: a
Blackberry1M smart phone, a Bluetooth-enabled glucometer and automated home blood
pressure monitor, as well as a pedometer and blood glucose test strips. Training was
provided on all devices at this visit. Self-monitored glucose measurements were to be
submitted twice daily: once before breakfast and again before going to bed. Pedometer
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data was entered manually at the end of each day. Home blood pressure readings were to
be collected 3 times/week as follows: Sunday, Tuesday, and Thursday. The Stages of
Change for Physical Activity Questionnaire was sent to the participants’ Blackberrys™
every week. Blood glucose measurements from the glucometer and blood pressure
measurements from the home blood pressure monitor were wirelessly transferred to the
patient’s Blackberry1M. Pedometer data was entered manually. All patient data was then
submitted in real time from the BlackberryIM Smart phones to a secure, encrypted
database supplied by HealthAnywhere1M and managed by Sykes Canada.
3.2 Study population
3.2.1

Inclusion and exclusion criteria
Participants (n=25) included 18 females and 6 males living in rural communities

surrounding Seaforth, Ontario. They were between the ages of 28 and 72 years old and
had two or more symptoms of metabolic syndrome. This included high risk patients with
elevated blood glucose, high blood pressure, elevated cholesterol and/or triglycerides, low
HDL cholesterol, high waist circumference, or obesity.
Participants were excluded from the study if they had uncontrolled or severe
hypertension (systolic > 180mmHg or diastolic > 1lOmmHg), type 1 diabetes, a history of
cardiovascular disease or angina, symptomatic congestive heart failure, unstable
pulmonary disease, or second to third degree heart block. Patients on medications known
to affect heart rate or other medications that might cause a co-intervention effect were
also excluded. Additionally those who had started or changed dose of a lipid-lowering
agent within the last 3 months were not included. Individuals with pacemakers, unstable
metabolic disease (e.g. thyroid disease), or orthopaedic or rheumatologic problems that
could impair exercise ability were not included. Lastly, patients with a history of
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problems with drugs or alcohol, and those with emotional, cognitive, or psychiatric
problems were also excluded.
3.2.2

Recruitment
Patients were recruited using an advertisement in the local newspaper in Seaforth,

Ontario, Canada. From there word-of-mouth was highly effective in recruiting patients
for the study.
3.3 Study intervention
All clinic visits took place at the Gateway Rural Health Research Institute in
Seaforth, Ontario, Canada. Stage-matched STEP1Mtest exercise prescription was
performed by a certified Kinesiologist. Stage of change was assessed using the Stage of
Change for Physical Activity Questionnaire (Marcus, Selby, Niaura, & Rossi, 1992).
Participants’ current cardiorespiratory fitness level was assessed using the self-paced
submaximal aerobic fitness STEP1Mtest (Petrella, Koval, Cunningham, & Paterson,
2001). The STEP™ test is a timed self-paced stepping test that involves stepping up and
down two 20 cm tall steps at a normal pace. Participants’ predicted maximal aerobic
capacity is calculated using the equation: V0 2 max = (((1511/time) x (weight/heart rate)) x
0.124) - (age x 0.032) - (sex x 0.633) + 3.9, where heart rate is in seconds, weight is in
kilograms, and female = 2, male = 1. Normative data is then used to place participants in
a fitness category (low, fair, Average, good, or high). Fitness level, stage of change for
physical activity, and exercise counseling are then used to prescribe appropriate exercise
to the individual.
During counseling participants were asked questions about their activity
preferences and current activities to come up with an appropriate exercise prescription
tailored to their unique fitness level, abilities, and needs. Exercise prescription followed
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the ACSM guidelines (American College of Sports Medicine, 2000). The FITT principles
of frequency, intensity, type, and time were used to specify the amount and type of
exercise to be done each week. An exercise heart rate of 70-85% of age-predicted
maximal heart rate was also given to the patient. Patients set physical activity goals
including a pedometer goal for the next 4 weeks using the SMART principles of goal
setting (Specific, Measurable, Attainable, Realistic, and Timely). An ultimate goal of
10,000 steps/day was recommended to the patients (Tudor-Locke & Bassett, 2004). It was
also advised that patients should see what their regular steps/day were and then strive to
improve by 1000 steps/day which represents a more attainable goal for some individuals.
Participants also received a booklet of activities to work on at home that corresponded to
their stage of change.
Counselling was individualized for each participant according to their stage of
change and their fitness level in order to provide the best intervention for each person.
For example, for a participant in the contemplation stage for physical activity with a
fitness rating of “Fair”, counselling focused on processes of change such as consciousness
raising, self réévaluation, and self-liberation. Examples o f consciousness raising include
increasing the participant’s awareness of the benefits (pros) of becoming physically
active, recognition of perceived barriers and potential solutions to overcome them, and
recognition of current behavioural patterns. Self-reevaluation involves thinking about
how being physically active might improve your life and how continuing to be inactive
may be detrimental. Lastly, self-liberation involves making a commitment to change
one’s behaviour. This often occurs after a person has decided that the pros of changing
outweigh the cons and marks the transition from the contemplation stage to the
preparation stage. Importantly, individuals in different stages of change for physical
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activity received a stage-appropriate intervention, focusing on the processes of change
appropriate for them.
For the technology portion of the intervention each patient received a DaTA kit
containing several technological devices: a BlackberryIM Smart phone with a 2 month
data plan, a pedometer, a Bluetooth-enabled glucometer, and a home blood pressure
monitor. Blood glucose test strips, instructions, and a handout on troubleshooting were
also provided. Participants received training and instruction on each of the devices and
when to measure each variable. They were also provided with contact information in
case they had concerns or problems before their next clinic visit.
3.4 Outcome measures
3.4.1

Adherence
Adherence was measured as the average percentage of readings actually received

out of the total possible number of readings expected from each participant. Participants
received an automatic reminder on their Blackberry1Msmart phone every time a reading
was scheduled to be taken. Blood glucose was measured twice each day: once while
fasted before breakfast and once before bed. Blood glucose measurements were taken
using a Bluetooth-enabled One Touch glucometer and corresponding test strips (Lifescan
One Touch Ultra2 and Polymap wireless adaptor PWR-08-03). Data from the
glucometers was automatically transferred to the participant’s BlackberryIM Smart phone
via Bluetooth connection and then sent to the secure HealthAnywhereIMdatabase. Blood
pressure and resting heart rate was taken 3 times per week: Sunday, Tuesday, and
Thursday. Patients were instructed to sit down in a quiet place where they could rest their
left arm at chest level, put the blood pressure cuff on, and sit quietly for 3-5 minutes
before taking their reading. Measurements were taken using a home blood pressure
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monitor (A & D Medical #UA-767PBT). Data were sent via Bluetooth technology from
the monitor to the Blackberry™ cell phone and sent to the Health Anywhere ™ database in
real-time. Daily physical activity was measured as steps/day using a pedometer (Omeron
# HJ-150). Patients received an automated reminder from their Blackberry™ at the end of
the day instructing them to manually enter their steps for the day. Bluetooth-enabled
pedometers were unavailable at the time of the study. Weight was also entered manually
by the patients once a week.
3.4.2 DaTA Study Technology Experience Data
Participants’ perceptions of the technology were assessed using the DaTA Study
Technology Experience Survey. Participants were asked to complete the survey at visit 2
and visit 3 to the research clinic. The survey consisted of 28 questions and assessed
previous technology experience, comfort level, ease of use, perception, and burden of
using the technology.
3.4.3 Effectiveness
The primary outcome o f effectiveness of the intervention was stage of change for
physical activity. Secondary outcomes of effectiveness included physical activity, fitness,
and cardiovascular risk factors. Stage of change was measured using the self-reported
Stage of Change for Physical Activity Questionnaire on visit 1 versus visits 2 and 3 as
part of the STEP™ test protocol. Stage of change was also measured weekly on the
participants’ Blackberry™ smart phone to provide feedback to the participants about their
progress. Changes in physical activity were quantified as mean steps/day during week 1
compared to weeks 4 and 8 of the intervention. Changes in fitness were measured as
predicted VC^max using the STEP™ test protocol on visit 1 compared to visits 2 and 3.
Changes in cardiovascular risk factors included comparisons of the following variables at
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visit 1, visit 2, and visit 3: serum triglycerides, HDL-cholesterol, LDL-cholesterol, total
cholesterol, weight, waist circumference, BMI, systolic and diastolic blood pressure, and
C-reactive protein.
3.5 Data Management and statistical analysis
3.5.1 Data management
Despite the fact that this was a small pilot study, the amount of data collected was
very large. All self-monitoring outcome data was encrypted and automatically transferred
from patient Blackberrys ™ to a HealthAnywhere1M database using Secure Socket Layer
protocols and signed certificates. Data was transferred exclusively over secured links and
messages did not contain any personal identification information. Health AnywhererM is
an Ontario-based company designed for secure handling, transmission, and storage of
confidential patient information. Health Anywhere1Mprovides a web-based interface that
services queries and operations that result in the addition of new patient records or adds to
existing records. Messages transmitted between the HealthAnywhere1Mserver and
participants’ Blackberrys™ follow the guidelines for Health Level Seven (HL7) domain
Common Message Element Types (CMETs). “Level Seven” refers to the applications
level of the International Standards Organization (ISO) model of communications for
Open Systems Interconnection. This is the level that interfaces directly to and performs
application services (hl7.org, 2010). HealthAnywhere1Muses the HL7 domain to
transform input from the Blackberry1M Smart phones into electronic patient health
records on the secure HealthAnywhere™ database. The company complies with the
Health Insurance Portability and Accountability Act which protects personal health
information. Personal patient information is guaranteed to be secure and is not transmitted
with the data captured from self-monitoring devices. Patients provided consent to transmit
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their Secure Socket Layer (SSL) encrypted data to HealthAnywhere1Mfirewall-protected
server. Server access is restricted to authorized personnel at the hosting center. Only
authorized logins are permitted using Secure Shell (SSH) encrypted tunnel with a valid
username and password.
HealthAnywhere1Mprovides secure database access to health care professionals
with a valid user ID and password. Access and use is restricted to authorized personnel
who must be authenticated via Java-based authentication libraries. The health care
professional portal allows clinical administrators to manage patient information and
regulate clinician and patient accounts within their clinician team. Clinicians are only
able to view patient information for the patients belonging to their specific database,
protecting patient confidentiality.
Clinic data were collected on the case report form for each patient and securely
stored in binders at the Gateway Rural Health Research Institute in Seaforth, Ontario,
Canada.
3.5.2

Statistical analysis
A one-way repeated measures ANOVA was conducted to compare clinical

outcomes at baseline, 1 month, and 2 month visits, and for self-monitoring data at weeks
1,4, and 8. Post-hoc analysis using a Bonferroni correction was performed to assess
differences between groups when the ANOVA showed statistically significant differences
between the groups. A paired t-test was used to compare results of the DaTA Study
Technology Experience Survey at 1 month and 2 months of study intervention. Statistical
significance was set at p < 0.05 and all analyses were performed using SPSS. Adherence
to self-monitoring protocols was calculated by manually picking out missed data points
from the uploaded data file. Self-monitoring data that was entered between the hours of
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midnight and 5am was considered as data from the previous calendar day. Missing data
were handled using the last outcome carried forward approach.
3.6 Ethics Approval
The study was approved by the Health Sciences Research Ethics Board of the
University of Western Ontario and by the Clinical Research Impact Committee at
Parkwood Hospital, London, Ontario.
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CHAPTER FOUR - RESULTS
4.1 Study population and demographics
A total of 25 adults between the ages of 28-72 (mean age 57 ± 9) were recruited
for the study. One patient withdrew from the study after 1 week due to an unrelated
medical problem. All remaining participants completed the study. Participant baseline
characteristics are presented in Table 3. At baseline, participants fulfilled the criteria for
metabolic syndrome. Additionally, 25% of the participants were type 2 diabetics.

45

4.2 Feasibility
4.2.1 Adherence
Adherence to self-monitoring protocols was high.

Table 4
P a rtic ip a n t A dh eren ce to S elf-m on itorin g P ro to c o ls d u rin g the 2 M on th D aT A Study

Self-monitoring Variable

Adherence (%)

Pedometer (daily)

97.7

Blood Glucose (am)

95.3

Blood Glucose (pm)

94.6

Weight (weekly)

98.4

Blood Pressure (3x/week)

97.4

N otes: Values represent percentage of required readings submitted. Superfluous data points submitted by

participants were not included in the analysis of adherence to the self-monitoring protocol. Participants that
completed fewer or more than 8 weeks of the intervention were assessed using the total number of data
points expected for the entire duration of their enrolment.

4.2.2 DaTA Study Technology Experience Survey
Results of the DaTA Study Technology Experience Survey showed no significant
changes from Visit 2 to Visit 3. Table 5 provides a summary of the survey data. Scores
on the DaTA Study Technology Experience Survey indicate that patients had infrequently
used monitoring devices prior to the study. Comfort level of using the devices was high,
with the mean values for each devices ranging between 3 (“agree”) and 4 (“strongly
agree”).

Participants found the Blackberry™ display screen easy to read, and study
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instructions easy to understand. Overall, participant acceptability of the technology was
high and perceived burden was low. Most patients reported that it took < 20 min to
perform the self-monitoring each day. There were no significant differences between
responses at V2 and V3.

Table 5
R esp o n ses fro m the D aTA T echn ology E xperience S u rvey a t 1 month a n d 2 m onths

Question

V2

V3

1. Currently use a Personal computer (%)

87.5

87.5

2. Currently use Internet (%)

70.8

79.2

3. Currently use Cell phone (%)

50

58.3

4. Currently use a PDA (%)

20.8

16.7

5. Currently use an Mp3 Player (%)

4.2

4.2

6. Currently use a Game system (%)

4.2

0

7. Currently watch Television (%)

58.3

66.7

8. Currently listen to the Radio (%)

75

75

9. How often have you previously used a PDA, Blackberry™ or
similar device?

1.33 ±0.87

1.46 ± 1.06

10. How often have you previously used a blood pressure cuff at
home?

2.29 ± 1.33

2.25 ±1.29

11. How often have you previously used a blood glucose monitor at
home?

1.83 ± 1.34

1.88 ± 1.33

12. How often have you previously used a pedometer (step counter)
at home?

1.70 ±0.95

1.54 ±0.93

13.1 am comfortable using a Blackberry™ to complete the study.

3.75 ±0.44

3.58 ±0.78

14.1 am comfortable using a blood glucose monitor to complete the
study.

3.96 ±0.20

3.79 ±0.66

15. Iam comfortable using a blood pressure monitor to complete the
study.

3.83 ±0.48

3.67 ±0.87
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16. Iam comfortable using a pedometer to complete the study.

4.00 ± 0

3.83 ±0.64

17.1 am comfortable using a heart rate monitor to complete the
study.

3.83 ±0.38

3.75 ±0.68

18. The display screen on the Blackberry™ was easy to read.

3.79 ±0.41

3.63 ± 0.65

19. The instructions were easy to understand.

3.71 ±0.55

3.50 ±0.66

20. The devices did not cause me any physical discomfort.

3.54 ±0.72

3.83 ±0.38

21. The self-monitoring events were easily scheduled into my daily
activities.

3.54 ±0.66

3.54 ±0.59

22. When I had technical problems with the devices, the problem
was resolved within 24h.

3.60 ±0.50

3.75 ±0.44

23. Participation in this self-monitoring program gave me a sense of
security.

3.43 ±0.51

3.58 ±0.50

24. Use of the self-monitoring technology helped me adopt new
practices that improved my well being.

3.42 ±0.72

3.83 ±0.38

25. Managing the technology used in the DaTA study took too much
time in my day.

1.38 ±0.58

1.25 ±0.44

26. Managing the technology used in the DaTA study interfered
with other activities of daily living.

1.46 ±0.59

1.33 ±0.48

27. How much time did using the DaTA study technologies require
per day?

1.00±0

1.08 ±0.28

N otes: The first 8 items were yes/no questions; they are expressed as the percentage of responders who

checked “yes”. All other values are means ± standard deviation. Questions 9-12 were measured on a 4-point
scale from 1 to 4 with: 1 = never, 2 - rarely, 3 - sometimes, and 4 = frequently. Items 13-26 were measured
on a 4-point scale from 1 to 4 with: 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 = strongly agree.
Question 27 was measured as follows: 1 = <20 min, 2 = 20-40min, 3 = 40-60min, and 4 - >60min.

4.3 Effectiveness
4.3.1 Stage of Change
A Chi Square non-parametric test was performed to assess differences in stage of change
at V I, V2, and V3 (Table 6). Mean stage of change increased from 3.8 ±1.1 to 4.6 ± 0.5
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from baseline to V3. This result was statistically significant (p=0.001) and represents an
overall shift from the Preparation stage to the Action stage of the Transtheoretical Model
in the study participants {Figure 2).
Table 6

F req u en cy o f sta g e s o f chan ge a t VI, V2, a n d V3 in the D aT A stu dy

Stage

VI

V2

V3

Contemplation (2)

3

0

0

Preparation (3)

8

3

1

Action (4)

3

3

3

Maintenance (5)

10

18

20

61
*
5
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F igu re 2. Mean Stage of Change at baseline, 1 month (Visit 2), and 2 months (Visit 3) of the DaTA Study.

Stage of change was measured using the Stage of Change for Physical Activity Questionnaire. Scoring is as
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follows: 1 = pre-contemplation, 2 = contemplation, 3 = preparation, 4 = action, and 5 = maintenance. All
values are means ± standard error. *lndicates significant change from baseline value.

4.3.2 Physical Activity
Mean steps per day increased significantly from week 1 to week 8. As seen in
Figure 3, participants walked an average of 5579 ± 1964 steps/day during the first week
of the study and this increased to 7818 ± 4235 steps/day during week 8 o f the study
(p=0.02). Mean steps/day during week 1, week 4, and week 8 were calculated to reduce
the effects of day-to-day variation in physical activity and provide a more reliable
estimate of average steps/day.
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F igure 3. Steps/day during Week 1, 4, and 8 of Participation in the DaT A Study. Mean steps/day for each

participant were calculated using pedometer data submitted during the first 7 days, days 22-29 (week 4),
and days 49-56 (week 8) following study commencement. Values are group means ± standard error.
"■Indicates a statistically significant difference compared to week 1.
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4.3.3 Cardiorespiratory Fitness
All patients were able to complete the STEP™ test. Time to complete the STEP1M
test decreased significantly from baseline to V3 (2 months). The mean difference in time
to completion between baseline and V3 was 14.3 s (95% Cl, 6.7-21.9, p<0.05) {Figure 4).
Predicted VChmax increased significantly from 29.5 ± 5.6 mL/kg/min'1 at baseline to 34.6
± 7.0 mL/kg/min'1 at 2 months, (p<0.05). Mean difference between baseline and 2 month
predicted V 0 2max was 5.1 mL/kg/min"1 (95% Cl, 2.5 ± 7.7 mL/kg/min'1, p<0.05). This can
be seen in Figure 5. Rating of perceived exertion (RPE) on the modified Borg scale did
not change. No significant changes in resting or post-exercise heart rate were found
{Figure 6).

120

</>
■o

Visit

F igure 4. STEP1™ Test Time-to-completion at Baseline, 1 month, and 2 months. Values are means ±

standard error. "Indicates a statistically significant difference compared to baseline.
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F igu re 5. STEP™ Test Predicted V 0 2max at Baseline, 1 month, and 2 months. Values are means ± standard

error. ’•‘Indicates a significant difference compared to baseline.
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□ Resting
Heart Rate

1

2

3

Visit
F igu re 6. STEP™ Test Resting and Post-exercise Heart Rate at Baseline, 1 month, and 2 months.

All

values are means ± standard error.

4.3.4 Cardiovascular risk factors
4.3.4.1 Self-mon itoring
Daily morning glucose dropped significantly after the first week due to the
discovery of type 2 diabetes in one patient. Daily evening blood glucose did not change
significantly during the 2 month intervention. A slight negative linear relationship
between morning and evening blood glucose was evident (Figure 7).
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F igure 7. Mean Blood Glucose Levels collected via Home Self-monitoring Technologies at 1 week, 4

weeks, and 8 weeks.

Figure 8 shows body weight over the 8 week study. No significant changes in
body weight occurred.
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1

4

8

Week

F igure 8. Self-monitored Body Weight of Participants at Week 1,4 and 8. Weight was measured in

kilograms using the same scale of each participant’s choosing. Values were entered manually into the
Blackberry™ by the participants and transferred in real time to the Health Anywhere e-health database.
Values are means ± standard error over 7 days.

Self-monitored resting diastolic and systolic blood pressure did not change
significantly during the study. Results are displayed below in Figure 9.
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F igure 9. Self-monitored Systolic (SBP) and Diastolic (DBP) Blood Pressure at 1 week, 4 weeks, and 8

weeks of the DaTA study.

Systolic and diastolic blood pressure is measured in mmHg. Each week

represents the group mean over 3 readings/week.

4.3.4.2 Clinic data
Table 7 summarizes the changes in clinical outcomes during the DaTA study.
BMI decreased significantly from 33.1 ± 4.4 kg/m 2 at baseline to 32.8 ± 4.3 kg/m2 at 1
month. These changes from baseline remained significant at 2 months. No other
significant changes occurred. Diastolic blood pressure decreased from 84 ± 9 mmHg at
baseline to 80 ± 13 mmHg, (p = 0.06). Blood glucose was 6.0 ± 2.4 mmol/L at baseline
and 5.63 ± 1.4 mmol/L at 2 months, (p = 0.522). Total cholesterol was 5.48 ± 1.3 mmol/L
at baseline and 5.19 ± 1.1 mmol/L at 2 months, (p = 0.069). No change was seen in waist
circumference, H bA lc levels, triglycerides, HDL cholesterol, LDL cholesterol, total
cholesterol, or systolic blood pressure.
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Table 7
C a r d io v a s c u l a r R is k F a c to r s a t b a s e lin e , 1 m o n th , a n d 2 m o n th s o f th e D a T A S tu d y

V2

VI

V3

Outcome
FValue

Mean

SD

Mean

SD

Mean

SD

6.0

2.4

5.6

1.4

5.6

1.4

0.66

0.522

6.0

1.0

6.0

1.0

6.0

1.0

1.495

0.235

1.3

0.3

1.4

0.4

1.4

0.4

0.161

0.852

LDL Cholesterol
(mmol/L)

3.4

1.2

3.2

1.1

3.1

1.1

0.228

0.797

HDL Cholesterol
(mmol/L)

1.3

0.3

1.3

0.41

1.4

0.4

0.226

0.796

Total Serum
Cholesterol
(mmol/L)

5.5

1.3

5.3

1.1

5.2

1.1

2.827

0.069

Triglycerides
(mmol/L)

1.8

1.3

1.7

1.3

1.7

1.2

1.887

0.163

C-Reactive
Protein (mmol/L)

4.0

2.3

4.0

2.3

3.5

2.2

1.243

0.298

Waist
circumference
(cm)

112

9

108

11

108

12

1.578

0.222

BMI (kg/m2)

33.1

4.4

*32.8

4.3

*32.7

4.3

4.568

0.016

Systolic BP
(mmHg)

141

9

137

13

139

19

0.405

0.669

Diastolic BP
(mmHg)

84

9

79

10

80

13

2.993

0.06

Glucose
(mmol/L)
HbAlc (%)
HDL Cholesterol
(mmol/L)

P-value

N ote: F-values and p-values were calculated using a repeated measures ANOVA. indicates that there was

a significant difference from baseline.
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4.4 Adverse events
One participant withdrew from the study within the first week due to an unrelated
medical problem. There were no other adverse events to report.
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CHAPTER FIVE - DISCUSSION
5.1 Overall findings
The results of the DaTA pilot study show that the technology is a feasible and
effective intervention delivery method in a population of high risk rural adults. The use
of this technological approach encourages adherence to self-monitoring of blood pressure,
heart rate, blood glucose, and daily physical activity. The results support our original
hypotheses that compliance to self-monitoring protocols would be at least 50% and that
participants would have positive views of the technology, finding it comfortable, easy-touse, and of low burden.
Stage of change changed significantly with an overall shift from the preparatory
stage to the action stage. This indicates an increased readiness to be physically active and
shows that the technology-based intervention was effective in motivating participants to
increase their physical activity. Participants increased their physical activity and
improved predicted V02max Contrary to expectations, few significant changes in
cardiovascular risk factors occurred from baseline to 2 months. BMI decreased
significantly while no other changes were seen. This may reflect the low number of
participants in enrolled in the study (low power) or the short duration of the study
intervention.
The DaTA study showed that self-monitoring devices paired with data
management and adherence reminders via Blackberry1Mcell phone are acceptable and
effective in assisting participant adherence to a stage-matched STEP™ test exercise
prescription intervention over 2 months. The intervention helped participants increase
their physical activity behaviour and improve their aerobic fitness. A longer study is
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planned to assess the long-term effectiveness of this intervention in reducing
cardiovascular risk factors in a rural population with metabolic syndrome.
5.2 Feasibility
Our initial hypothesis that patient adherence would be 50% was supported by the
study results. Adherence to self-monitoring protocols was high (>94% for all readings),
reflecting the strong acceptability of the technology to the participants. Results from the
DaTA Study Technology Experience Survey show that the majority of study participants
agreed or strongly agreed that the technology devices were easy to use and understand,
and that they were comfortable using them for the study (Table 6).
Our study findings also show that middle-aged adults in rural Ontario are open to
learning how to use new technology. The mean age of our sample was 57 and only 50%
of the participants were currently using a cell phone. Results from the DaTA Technology
Experience Survey show that participants had infrequently used the self-monitoring
devices or a BlackberryIM in the past but were comfortable using the pedometer, blood
pressure monitor, glucometer, and BlackberryIM during the study.
Most participants found that the self-monitoring did not require more than 20
min/day and was easy to schedule into their daily activities (Table 6). Participants
perceived the technology as being helpful in helping them adopt new habits that were
beneficial to their wellbeing. The majority of participants also disagreed or strongly
disagreed that using the technology took up too much time or interfered with other
activities.
Previous studies using at-home monitoring devices support these findings. In
2008, Liddy and colleagues performed a pilot study in a semi-rural area of North-eastern
Ontario investigating the feasibility and acceptance of a telehealth monitoring system for
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patients with multiple chronic diseases. In this study a variety of self-monitoring devices
including a blood pressure monitor and a glucometer connected to a telehealth unit that
collected and transferred patient data to a secure web-based server using patients’
telephone lines. Patient information could then be accessed and reviewed by the patients’
health care providers. This is similar to the technological design of the DaTA study
except we employ the use of a Blackberry1Msmart phone instead of a telehealth unit.
Since cell phones are now popular devices with a variety of functions, it is thought that
this may be more practical and cost-effective for patients than a single-use device.
Results o f this study showed that patients were “overwhelmingly positive toward home
health monitoring” and that the majority of patients found the technology useful and easy
to use (Liddy et al., 2008).
Overall, the findings of the study show that pairing the STEP™ test exercise
intervention with self-monitoring and Blackberry™ technologies was feasible. High
adherence to the self-monitoring protocols suggests high participant motivation to
improve physical activity and health. This is supported by the significant improvements
made in physical activity and cardiorespiratory fitness over the 2 month study.
Furthermore, the technology was acceptable and easy-to-use for participants. Positive
perceptions and high adherence to self-monitoring protocols shows that the intervention is
feasible and provides support for initiating a larger randomized controlled trial.
5.3 Effectiveness
5.3.1 Stages of Change
Stage of change for physical activity represents an individual’s psychological
readiness to change their physical activity behaviour (Prochaska & DiClemente, 1982).
Mean baseline stage of change was high for the participants in our study, likely reflecting
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the fact that volunteers are generally highly motivated. The baseline mean score of 3.8
falls between the preparation stage (3) and the action stage (4). At baseline ten
participants had already been exercising for at least 3 months (maintenance stage), while
eight were in the preparation stage, three were contemplators, and three were in the action
stage. On average, participants increased their stage of change by almost 1 stage by the
end o f the study. This was a major finding (p=0.001), demonstrating that the intervention
was effective in increasing participants’ readiness for physical activity. Participants who
were in the maintenance stage at baseline remained there (experienced no change), while
those in the contemplation, preparation, and action stages progressed at least one stage, if
not two. The results also showed that nobody relapsed into a previous stage of change.
According to Prochaska & DiClemente (1982) relapse-prevention is a key focus of the
maintenance stage, though it can happen (and often does) at any stage. Most participants
(23/24) were in the action or maintenance stage at the end of two months, indicating that
the intervention was successful in improving participants’ readiness to be physically
active. This is supported by the participants’ significant increase in steps/day and
cardiorespiratory fitness during the study.
Previous physical activity trials have showed good short-term results regarding
stage o f change progression in sedentary adults. Calfas et al. (1996) showed that a
Transtheoretical Model approach to increasing physical activity can be effective in
facilitating increased physical activity readiness. In their 6-week randomized trial, 52% of
participants in the intervention group became regularly physically active by the end of the
trial compared to 12% of the control group. A review by Hutchinson et al. (2008) also
reports positive changes in stage of change in 18/24 short-term (< 6 months) physical
activity interventions based on the Transtheoretical Model.
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To date few studies have applied a Transtheoretical Model-based exercise
intervention to a metabolic syndrome population. The SNAC study used the STEPrM test
exercise prescription in a sample of high-risk adults with pre-diabetes and/or pre
hypertension but did not report data for stage of change as it was not the primary focus of
the study (Aizawa, Shoemaker, Overend, & Petrella, 2009). The current study shows that
an intervention pairing the STEPIM test exercise prescription with self-monitoring and
Blackberry™ smart phone technology results in stage progression in metabolic syndrome
adults in rural Ontario. The results also suggest that the intervention may be helpful in
preventing stage regression (relapse).
5.3.2 Physical activity & cardiorespiratory fitness
Physical activity increased significantly from baseline to V3 (2 months) in the
current study. Mean steps per day increased from 5579 ± 1964 steps/day during the first
week of the study to 7818 ± 4235 steps/day during week 8, (p = 0.02). These findings
align with those from other studies. In a systematic review o f the literature pedometer use
was found to increase physical activity by an average of 2491 steps/day compared to non
pedometer control (Bravata et al., 2007).
Although significant increases in steps/day were achieved by the participants in
this study they were well under the 10,000 steps/day recommended (Government of
Ontario, 2010; Tudor-Locke & Bassett, 2004). 10,000 steps is equivalent to about 8 km (5
miles) and public health documents insist that it should be easy to achieve with an active
lifestyle (City of Ottawa, 2004; Government of Ontario, 2010). A systematic review by
Bravata et al. highlights the effectiveness of pedometers and having a goal of 10,000
step/day for helping people increase their daily physical activity despite the reality that
few people actually achieve that many steps (Bravata et al., 2007). Furthermore changes
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in steps/day in the current study had a moderate effect size, despite not meeting the goal
of 10,000 steps/day.
The DaTA intervention improved participants’ pedometer-measured physical
activity. Mean daily steps increased by 41% from week 1 to week 8. This is well above
the mean 26% increase in steps/day found by Bravata et al. (2007). Some participants in
our study did achieve the goal of 10,000 steps/day though this may not reflect the typical
response of metabolic syndrome patients since volunteers are generally more motivated
than non-volunteers. Nevertheless, the intervention successfully helped patients increase
their walking behaviour in the short-term.
Individual exercise prescriptions were tailored to include other activities along
with walking. Several participants took part in other physical activities that are not
conducive to pedometer monitoring. Activities such as cycling, swimming, resistance
training, and even vibration machine exercise were performed by some o f our
participants. Walking was the most accessible and preferred mode of physical activity
and the pedometer captured that data in a cost-effective and reliable manner. In
retrospect, an exercise journal or accelerometer may have been an effective way to
capture non-walking data which may have had an impact on study outcomes.
Although pedometer data is self-reported, the literature supports the use of
pedometers as a reliable and valid measurement of physical activity (Tudor-Locke,
Williams, Reis, & Pluto, 2002). Improvements in predicted V02max also suggest that
physical activity increased over the course of the study. For example, aerobic fitness
increased significantly despite an insignificant change in weight. This is also important
because V02max can be improved simply by losing weight. Since our participants did not
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lose a significant amount of weight, the improvements in fitness are not caused by weight
loss but rather by increased physical activity.
Aerobic fitness is an important indicator of cardiovascular health and has been
associated with decreased risk of cardiovascular disease and all-cause mortality (Myers,
Prakash, & Froelicher, 2002). Metabolic syndrome is associated with poor aerobic fitness
(Brien, Janssen, & Katzmarzyk, 2007). Aerobic fitness declines with age, largely due to
disuse. Generally as people age they become more sedentary, but there is also
physiological decline of the cardiovascular system with age regardless of physical activity
levels (Hawkins & Wiswell, 2003). Endurance capacity generally decreases by 10% per
decade after age 30 (Heath, Hagberg, Ehsani, & Holloszy, 1981). There is a great deal of
variability in aerobic capacity due to genetics, physical activity levels, gender, age, and
lean body mass. Typically untrained sedentary adults have a maximal aerobic capacity
ranging anywhere from 15.0 mL/kg/min'1 to 32 mL/kg/min'1 (Huang, Gibson, Tran, &
Osness, 2005). This agrees with the findings from our study which show baseline mean
V02max values of 29.5 ± 5.6 mL/kg/min'1 for middle-aged adults. Aerobic training can
improve aerobic fitness regardless of age. Improving aerobic fitness can reduce ageassociated declines in aerobic capacity. Studies show that aging athletes lose aerobic
fitness at a rate of 5-7% per decade as opposed to 10% experienced by the average healthy
individual (Hawkins & Wiswell, 2003). The training effect of exercise slows the
structural and functional changes of the heart and vascular system that occur with aging,
and help preserve cardiac output. Work capacity declines with age because of reduced
oxygen delivery to the tissues and working muscles (Astrand, 1956).
The STEP1Mtest results show that aerobic fitness improved significantly over the
2 month study. As shown in Figure 7 predicted VC^max increased 17.2% over 2 months,
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from 29.5 ± 5.6 mL/kg/min'1 at baseline to 34.6 ± 7.0 mL/kg/min"1 at 2 months, (p<0.05).
Short term exercise training studies have been shown to improve aerobic fitness in at-risk
populations. Baynard at al. (2009) studied obese individuals performing 10 days of
treadmill walking at 70-75% of maximal aerobic capacity. This brief intervention
resulted in a modest increase of 5% in mean aerobic capacity from 24.6 ± 1.2 mL/kg/min"
1 to 26.0 ±1.1 mL/kg/min'1.
Improvements in aerobic fitness happen as a result o f physiological adaptations to
exercise. Short-term exercise training improves insulin sensitivity and glucose
metabolism. Toledo et al., 2008 demonstrated that an improvement in V02max by 12 ±
1.6% (p < 0.05) over 4 months of moderate-intensity exercise in type 2 diabetics was
accompanied by significant increases in mitochondrial density within skeletal muscle (67
± 17%, p < 0.01). Insulin sensitivity also improved by 59 ± 21% (p <0.05). A recent
study showed that 7 days of 60 min o f aerobic exercise training at -70% of V 0 2max
produces significant improvements in insulin action with no change in fasting glucose
levels in obese type 2 diabetics (Kirwan, Soloman, Wojita, Staten, & Holloszy, 2009).
This suggests that although we did not see significant changes in blood glucose levels
during our intervention, it is possible that improvements in insulin action occurred but
were not measured.
Measurement error may also be a factor. One limitation of the procedure is that
V 0 2max is dependent on exercise heart rate which is calculated from a 15 s palpation of
the radial artery rather than by an electronic heart rate monitor. There may also be a
learning effect resulting from repeated performance of the test.

66

5.3.3 Cardiovascular risk factors
A significant reduction in BMI occurred despite no changes in self-monitored
weight and waist circumference. No other changes in cardiovascular risk factors occurred
from baseline to 2 months. This is contrary to our initial hypothesis that there would be
moderate changes in cardiovascular risk factors from participation in the DaTA study.
5.3.3.1 Abdominal Adiposity
Waist circumference is an acceptable surrogate marker of abdominal obesity and
one criterion for diagnosing metabolic syndrome. While waist circumference decreased
from 112 ± 9 cm to 108 ± 8 cm this was not a statistically significant finding. These
values are still above the cut-off values for metabolic syndrome. A waist circumference >
102 cm in women or > 88 cm in men is considered high-risk (National Heart, Lung, and
Blood Institute, 2001). To lose another 6-20 cm around the midsection, participants
might need more than two months of physically active living. There is a dose-response
relationship between aerobic exercise volume and decreases in abdominal fat (Ohkawara,
Tanaka, Miyachi, Ishikawa-Takata, & Tabata, 2007). This suggests that the participants
in our study may have seen better results with further increases in physical activity
volume.
Although visceral fat is a risk factor for cardiovascular disease, there is evidence
that improving fitness levels improves cardiovascular risk factors such as triglycerides,
HDL cholesterol, and blood pressure, irrespective of visceral fat levels. Lee and
colleagues (2008) performed a systematic review, finding that for a given waist
circumference individuals with high aerobic fitness had lower triglycerides and higher
HDL cholesterol levels than those with lower aerobic fitness, (p < 0.05). Blood pressure
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was also higher in less fit individuals than more fit individuals with the same amount of
abdominal fat.
Self-monitored weight did not change significantly during the 2 month
intervention. This may be due to the short duration of the intervention. In a meta-analysis
of physical activity interventions using pedometers (with no concurrent dietary
interventions), there was a strong linear relationship between intervention duration and
weight change. Meta-regression results showed a mean weight loss of 0.05 kg/week, or 1
lb every 10 weeks (Richardson et al., 2008). While this is a very slow rate of weight loss,
there are still health benefits to be gained from increased physical activity regardless of
changes in weight.
Physiological benefits can be seen from moderate-intensity training interventions
lasting only 7 days in length (Kirwan, Soloman, Wojita, Staten, & Holloszy, 2009).
Though patients with high waist circumference are still at cardiovascular risk, being
physically active improves their overall risk profile. Individuals are not always aware of
the physiological improvements in their bodies and may get frustrated from lack of
visible progress. While weight loss and changes in body composition are important, they
take longer to accomplish. Thus physiological monitoring, fitness testing, and
progressive exercise prescription with goal setting can be helpful catalysts of long-term
behaviour changes with respect to physical activity since they emphasize positive changes
other than weight loss.
5.4 Limitations
The primary limitation of the current study is the lack of statistical power due to a
small sample size. However since the overall purpose of this pilot study was to assess the
feasibility and effectiveness of the intervention for a larger randomized controlled trial,

68

sufficient power was not expected. Another limitation to the study is the short duration. It
was proposed that 2 months was the minimum amount o f time necessary to see changes
in physical activity, aerobic fitness, and several cardiovascular risk factors. Evidence
suggests that short-term exercise interventions have higher adherence rates than long-term
interventions so potentially the results of the current study are not applicable to a longerterm intervention. Another limitation is that the DaTA Study Technology Experience
Survey was created for this study and lacks the methodological rigour of a validated
questionnaire. However, as a feasibility study, we were interested in collecting feedback.
Physical activity other than pedometer-measured walking was not collected during the
study. Although steps/day increased significantly it is likely that additional exercise
contributed to the increases in aerobic fitness that resulted from the 2 month intervention.
In the future capturing total energy expenditure and physical activity should be
considered. Having another device such as an accelerometer would be beneficial in
capturing non-walking/running type activity in future studies. Although our patients met
inclusion criteria the low subject number and self-selection o f volunteers may have
resulted in a sample characteristic of the lower end of the high cardiovascular risk
continuum. That being said, this is a pilot study to assess the feasibility and effectiveness
of this intervention in preparation for a larger trial. No participant was in the pre
contemplation stage at baseline. Unfortunately it is extremely difficult to recruit people
who are not even considering becoming physically active for a physical activity
intervention. This reduces the generalizability of the study, as it is unknown if those in
the pre-contemplation stage will respond the same way to the intervention as those who
are contemplating or preparing for changes in their physical activity behaviour.
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5.5 Conclusions
The results of this two month pilot study suggest that this novel intervention is a
feasible and effective method of implementing a physical activity intervention. As we
hypothesized, participant adherence to the intervention was >50% at -94% for all self
monitoring readings. Participants were comfortable using the technology, found it easyto-use, and did not perceive the technology to be a substantial burden in their everyday
lives. Participants had positive perceptions of the technology and found it helpful. The
DaTA study was effective in increasing physical activity readiness (stage of change) and
behaviour (steps/day), as well as physical fitness (VC^max)- We had hypothesized that
participants would experience moderate improvements in cardiovascular risk factors over
the two month intervention but the only significant change was a decrease in BMI.
Overall the results of this study show that this physical activity intervention combining
the STEP1Mtest exercise prescription with self-monitoring and Blackberry™ smart phone
technology is feasible and effective in increasing physical activity, stage of change, and
aerobic fitness.
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APPENDIX II
STEP TEST EXERCISE PRESCRIPTION
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Patient ID

Patient Initials

Date of Visit (day/month/year)

STEP TEST
Blood Pressure (BP-TRU™):

Take 3 [setting is for every 2 minutes]

Resting Heart Rate:

TIME COLLECTED:

bpm

Able to complete?
I

I 1 = Yes

Q

2 = No

If NO, number of steps completed:

I

l

I

Reasons for stopping
I

I 1 = Fatigue

0

2 = Musculoskeletal (i.e joint pain)

1

I 3 = Cardiovascular (i.e. chest pain)

Q

4 = Muscle Pain

[ ]

5 = Other, specify:

Heart Rate (after test):

Time:

Borg Score:

VO: tj,

Training Heart Rate

Training Heart Rate

min sec 1/100

sec
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APPENDIX III
DATA TECHNOLOGY EXPERIENCE SURVEY

DaTA Study
Technology Experience Survey
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Patient Initials:

Visit:

Da,e: □
First Mid. Last

S= screen, V1 or V2

□

□

DD/MM/YY

Technology Usage: What technology do you currently use? Please check boxes all that apply:

□□
CZl
d H

I—
I
I
I
I—

1. Personal computer
2- Internet

3. Cell phone
I 4. PDA
I 5. Mp3 player
I 6 Game system
I 7. Television
| a. Radio

Previous experience: Please check the box that applies and rate your previous experience with
the DaTA study technology. On a scale of 1 to 4 with: 1 = never, 2 = rarely, 3 = sometimes, 4 =
frequently.

9. Have you previously used a PDA, Blackberry or similar device?

1izz

2-[=z:

3 czzi

4- z z

10. Have you previously used a blood pressure cuff to monitor your own blood pressure?

1. HZ□

2 .Z Z

3. IZZI

4. [ZZI

11. Have you previously used a blood glucose monitor to measure your own blood glucose level?

1. I

I

2 .1

I

3. I

I

4.

I

I

12. Have you previously used a pedometer (step counter) to monitor your own daily activity level?
1. IZ Z ]
2. IZ Z I
3. Z Z I
4. z z
Comfort level: Please check the box that applies and rate the following statements by adding the
number to the box. On a scale of 1 to 4 where: 1 = strongly disagree, 2 = disagree, 3 = agree,
and 4 = strongly agree.

13. I am comfortable using a Blackberry to complete the study.

1.

ZZ

2. Z Z I

3- ZZH

4. Z Z

14. I am comfortable using a blood glucose monitor to complete the study.

1.

ZZ

2. Z Z

3. Z Z

4. Z Z

15. I am comfortable using a blood pressure monitor to complete the study.

1.

Z Z

2. Z Z I

3. Z Z

4. Z Z

16. la m comfortable using a pedometer to complete the study.
1. Z Z 2 .Z Z
3. Z Z
4. Z Z
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DaTA Study
Technology Experience Survey

□

Patient Initials:

Visit:

oate:D

First Mid. Last

S= screen, V1 or V2

D

D

DD/MM/YY

17. I am comfortable using a heart rate monitor to complete the study.
1.
2- [ = D
3.
4. [ Z Z I

[ZU

cm

Ease of use: Please check the box that applies and rate the following statements. On a scale of
1 to 4 where 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 ^strongly agree.

18. The display screen on the Blackberry was easy to read.
1.
3.
4.

\zz\

2. cm

cm

cm

19. The instructions were easy to understand.
1. |------- 1
2. |------- 1
3. |------- 1

4.

|------- 1

20. The use of the devices in the DaTA study did not cause me any physical discomfort. (Provide
list below).
1.
3.
iz z j

cm

* cm

cz\

4

21. The self-monitoring events were easily scheduled into my daily activities.
1.
2.
3. i z z i
4.

cm

cm

\cz\

22. When I had technical problems with the devices, the problem was resolved within 24 hours.
1.
2
3. [ z z i
4.

cu

.cm

cm

Perception: Please check the box that applies and rate the following statements. On a scale of 1
to 4 where: 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 = strongly agree.

23. Participation in this self-monitoring program gave me a sense of security.
1.
2 .C Z I
3.
4.

cn

cm

[CC]

24. Use of the self-monitoring technology helped me adopt new practices that improved my well
being.
1.
3. d Z I
4.

cm

2. cm

cm

Burden: Please check the box that applies and rate the following statements. On a scale from 1
to 4 where: 1 = strongly disagree, 2 = disagree, 3 = agree, and 4 = strongly agree.

25. Managing the technology used in the DaTA study took too much time in my day.
1.
3. i z z i
4.

cm

2.\cu

cm

26. Managing the technology used in the DaTA study interfered with other activities of daily living.
1.
2
3.
4. i— |

cn

.cm

\cz\

27. How much time did using the DaTA study technologies require per day? Please check one

box.
1 .< 2 0 m in s.|

| 2. 20 to 40 mins. |

| 3. 40 to 60 mins.I

____
I 4. > 60 mins. I
I

28. Provide a list of discomfort (s):_________________________________________________
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APPENDIX IV
STAGES OF CHANGE FOR
PHYSICAL ACTIVITY QUESTIONNAIRE

89

Patient ID

Patient Initials

Date of Visit (day/month/year)

.STAGE QF CHANGE; Physical Activity

Physical activity or exercise

walking briskly heavy housework, jogging, digging inthe garden, climbing
stairs or any other physical activity where the exertion is similar to these

=

Regular physical activity or exercise =

accumulating 30 minutes or more in the above activities most (5 or
more) days of the week

For example, you could:
1 Take ONE 30-minute walk
OR
2 Take THREE 10-minute walks OR
3. Do I0 minutes of heavy housework + 10 minutes of walking + 10 minutes of digging in the garden.
For each question below please mark YES or NO

□

ii

z

□

2 -

O

II

z

□ I = Yes

D

CN

1 =Yes

□

1 1amnot currently physically active and no plans to change
(ie. no walking briskly, heavy housework, jogging, digging in the garden, climbing stairs or any other
physical activity where the exertion is similar to these).
I f y e s . G iv e PA S te p 1

If

3

1intend to become more physically active in

yes,

G iv e

PA S te p 2

the next week
If

□

y e s , G iv e

P h y sica l A c tiv ity S tag e:

h

Physical Activity Stage:

No

□ 2 = No

G iv e PA S te p 4

5 1have been regularly physically active in the past for a period at least 3 months
If

8
>

□

yes,

1 =Yes

PA S te p 3

4 1have been regularly physically active but only less than 3 months
If

O

1intend to become more physically active inthe next month

CM

2

□

1 = Yes

□

2 = No

y e s , G iv e PA S te p 5

To be completed by study office ONLY
1

2

3

4

5
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APPENDIX V
ACTIVITIES FOR THOSE WHO ARE
THINKING ABOUT BECOMING PHYSICALLY ACTIVE
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STEP TWO:
ACTIVITIES FOR PEOPLE
WHO ARE THINKING ABOUT
BECOMING PHYSICALLY
ACTIVE

92

A C T IV IT IE S FOR PEOPLE W HO A R E T H IN K IN G A B O U T
B E C O M IN G P H Y S IC A L L Y A C T IV E

Your doctor has asked you to complete this set of activities based on the
questionnaire you completed regarding your intention to become physically
active OR you have completed the STEP ONE activities and are ready to
move on to STEP TWO.
We know that people go through different ‘STEPS’ in the process of
changing their behaviour. While many people think about becoming
physically active, it is not always easy to get started, so we suggest that you
do it in STEPS.
There are FIVE STEPS in the behaviour change process and you are
currently at STEP TWO for Physical Activity. The following activities are
designed to make it easier for you to move from STEP TWO to STEP
THREE.
At the moment some or all of the following probably apply to you:
• You are considering trying to become physically active
• You are not sure you can do it but are slowly feeling more confident
• Temptations not to become physically active are still high
• The ‘Pros’ of changing are about the same as the ‘Cons’
Complete the Activities on the following pages and if you are ready to move
on to STEP THREE then ask the Study Coordinator or your doctor for the
STEP THREE activities at your next visit.
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ACTIVITY ONE
PROS AND CONS OF BECOMING PHYSICALLY ACTIVE

This activity will help you decide whether or not you want to start becoming
physically active.
On the next page, write down your reasons for (PROS) choosing to become
physically active and reasons against (CONS) choosing to become
physically active.
Spend some time thinking about these reasons and try to be as honest as
possible with yourself. Think about things like:
•
•
•
•
•
•
•
•
•

Your energy level
Your health
Your social life]
Your time commitments
What your friends and family think
How you feel about yourself
How you cope with stress and frustration
What problems/barriers you may have to overcome
Your weight

Once you have written down your Pros and Cons give them a ‘weighting;
between 1 and 3 where:
1 = not very important to me
2 = important to me
3 = very important to me
At the end of the activity think about whether or not you want to become
physically active.
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PROS for becoming Physically Active

Weighting

CONS for becoming Physically Active

Weighting

If you have more Pros and/or you have weighted most of them 2 or 3 then
you are ready to move on to STEP 3. If you more Cons and/or you have
weighted most of them 2 or 3 go on to the next activity.
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ACTIVITY TWO
PHYSICAL ACTIVITY BARRIERS
What keeps you from being more physically active? Maybe you’re too busy at work. Or
perhaps your kids or other loved ones need you and they come first.
Brainstorm all the reasons you are not more physically active. Nothin is too big or too
small. Just write down all the things that come to mind. Some examples are given below
to help you get started.
My Barriers to Becoming Physically Active____________________________________
Not enough time
Too out of shape
Don’t like to sweat

Now, review your physical activity barriers. Which one is the biggest obstacle? List it on
the first line below. Prioritize the rest of your barriers from biggest to smallest.
1.

6.

2.

7.

3.

8.

4.

9.

5.

10.

Pick one barrier and come up with ways to get around it. Be creative! List your ideas
below.

Now pick one o f your ideas and try it for a week. If after a week it didn’t work, try
another strategy. Keep trying new ideas until you find some that help you overcome your
barriers.
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ACTIVITY THREE
PERSONAL TIME STUDY
Do you really know how you spend your time every day? This page will help you find
where you might be able to fit in more physical activity. Write in all your activities for
each four hour block of time in the chart below. In each four hour block, add up the
minutes you were active and put this in the “active” column. Subtract you ‘active’
minutes from 240 minutes (the total amount o f minutes in four hours) to get your
‘inactive’ time. At the end of the day, total the number of minutes that you were active
and inactive. Keep this sheet with you, in an easy to use place, and write things down as
you go. Record your activities for one week day and one weekend day to see how
differently you spend your time. Use a separate sheet for each day.

WEEK DAIr

Time Slot
Example:
12:01-4pm

Tasks/Activities
Washed dishes, 10 min; watched TV, 90
min; walked to mall, 15 min; met friend for
coffee, 35 min; walked home, 15 min;
napped, 60 min; talked on phone, 15 min

Midnight 4am
4:01am-8am

8 ^ la m noon

12:01pm4pm

4:01pm-8pm

8:01pm midnight

TOTAL TIME

Active
(minutes)

Inactive
(minutes)

30 min

210 min
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WEEKEND DAY

Time Slot
Example:
12:01-4pm

Tasks/Activities
Washed dishes, 10 min; watched TV, 90
min; walked to mall, 15 min; met friend for
coffee, 35 min; walked home, 15 min;
napped, 60 min; talked on phone, 15 min

Active
(minutes)

Inactive
(minutes)

30 min

210 min

Midnight 4am
4:01am-8am

8 ^ la m noon

12:01pm4pm

4 :01pm-8pm

8:01pm midnight

TOTAL TIME

Now go back and find time within your day when you can fit in more physical activity.
Write the times below:
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ACTIVITY FOUR
KEEPING TRACK OF THOUGHTS

Use this worksheet to record the number of times you think about doing
some physical activity. Simply place a check mark in a box in the right hand
column in Section 1. If you actually carried out your thoughts and did some
physical activity, place a checkmark in the right column in Section 2.
Keeping track of your thoughts can help you start moving toward a
physically active lifestyle.
Section 1

You thought about doing some

□ □ □ □ □ □ □ □ □ □ □ □ a

physical activity

□ □ □ □ □ □ □ □ □ □ □ □ a

□□□□□□□□□□□□a
□□□□□□□□□□□□□
□□□□□□□□□□□□a
□□□□□□□□□□□□a
Section 2

You actually did some

□ □ □ □ □ □ □ □ □ □ □ □ a

physical activity

□ □ □ □ □ □ □ □ □ □ □ □ a
□ □ □ □ □ □ □ □ □ □ □ □ a

□□□□□□□□□□□□a
□ □ □ □ □ □ □ □ □ □ □ □ a

□□□□□□□□□□□□a
How do you feel?

Are you ready to start making changes to your physical activity habits? If so,
ask your doctor or the study coordinator for the STEP 3 activities at your
next visit. If not, discuss the above activities with your doctor at your next
visit.

